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Whole genome comparisons identified introgression from 
archaic to modern humans. Our analysis of highly 
polymorphic HLA class I, vital immune system 
components subject to strong balancing selection, shows 
how modern humans acquired the HLA-B*73 allele in 
west Asia through admixture with archaic humans called 
Denisovans, a likely sister group to the Neandertals. 
Virtual genotyping of Denisovan and Neandertal genomes 
identified archaic HLA haplotypes carrying functionally 
distinctive alleles that have introgressed into modern 
Eurasian and Oceanian populations. These alleles, of 
which several encode unique or strong ligands for natural 
killer cell receptors, now represent more than half the 
HLA alleles of modern Eurasians and also appear to have 
been later introduced into Africans. Thus, adaptive 
introgression of archaic alleles has significantly shaped 
modern human immune systems. 
Whether or not interbreeding occurred between archaic and 
modern humans has long been debated (1, 2). Recent 
estimates suggest that Neandertals contributed 1-4% to 
modern Eurasian genomes (3) and Denisovans, a likely sister 
group to the Neandertals, contributed 4-6% to modern 
Melanesian genomes (4). These studies, based upon statistical 
genome-wide comparisons, did not address if there was 
selected introgression of functionally advantageous genes (5). 
We explored if the highly polymorphic HLA class I genes 
(HLA-A, -B and -C) (fig. S1) of the human Major 
Histocompatibility Complex (MHC) are sensitive probes for 
such admixture. Because of their vital functions in immune 
defense and reproduction, as ligands for T cell and natural 
killer (NK) cell receptors, maintaining a variety of HLA-A, B 
and C proteins is critical for long-term human survival (6). 
Thus, HLA-A, -B and -C are subject to strong multi-allelic 
balancing selection, which with recombination imbues human 
populations with diverse HLA alleles and haplotypes of 
distinctive structures and frequencies (7). 
An exceptionally divergent HLA-B allele is HLA-B*73:01 
(8, 9). Comparison with the other >2,000 (10) HLA-B alleles 
and chimpanzee and gorilla alleles from the same locus 
(MHC-B) shows that HLA-B*73:01 is most closely related to 
subsets of chimpanzee and gorilla MHC-B alleles (11) (figs. 
S2 to S4). This relationship extends throughout a ~9kb region 
of the B*73:01 haplotype (Fig. 1A), defining a deeply 
divergent allelic lineage (MHC-BII), distinct from the MHC-
BI lineage to which other human HLA-B alleles belong. These 
two lineages diverged ~16 million years ago (Fig. 1B), well 
before the split between humans and gorillas, but while 
MHC-BI comprises numerous types and subtypes, MHC-BII 
is only represented in modern humans by B*73:01 (fig. S5). 
HLA-B*73:01 combines ancient sequence divergence with 
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modern sequence homogeneity, properties compatible with 
modern humans having recently acquired HLA-B*73:01 
through introgression. 
In modern humans, HLA-B*73 is concentrated in west 
Asia, and is rare or absent in other regions (12) (Fig. 1C and 
fig. S6). This distribution is consistent with introgression of 
HLA-B*73 in west Asia, a site of admixture between modern 
and archaic humans (3). Also consistent with introgression is 
the linkage disequilibrium (LD) between B*73:01 and HLA-
C*15:05 (13), an allele having wider distribution than B*73, 
but concentrated in west and south-east Asia (Fig. 1D). 
Worldwide, ~98% of people carrying B*73 also carry 
C*15:05 (Fig. 1E and fig. S7). In Africans the LD reaches 
100%, but in west Asians it is weaker (~90%). These data are 
all consistent with introgression in west Asia of an archaic 
B*73:01-C*15:05 haplotype which expanded in frequency 
there, before spreading to Africa and elsewhere. HLA-B*73 is 
absent from Khoisan-speaking and pygmy populations who 
likely diverged from other Africans before the Out-of-Africa 
migration (14); (fig. S8). That Khoisan and pygmies uniquely 
retain ancient mitochondrial and Y-chromosome lineages (14, 
15), as well as MHC-BI diversity (fig. S8), suggest B*73 was 
probably not present in any African population at the time of 
the migration. These data argue for models in which modern 
humans acquired B*73 by archaic admixture in west Asia, 
and against models in which B*73 arose in Africa and was 
carried to other continents in the Out-of-Africa migration 
(Fig. 1F), as do the results of coalescence simulations that 
implement rejection-based approximate Bayesian inference 
(16) (α = 0.01-0.001) (figs. S9 to S11). 
By reanalyzing genomic sequence data (3, 4, 11), we 
characterized archaic HLA class I from a Denisovan and three 
Neandertals. The Denisovan’s two HLA-A and two HLA-C 
allotypes are identical to common modern allotypes, whereas 
one HLA-B allotype corresponds to a rare modern 
recombinant allotype and the other has never been seen in 
modern humans (Fig. 2B and fig. S12). The Denisovan’s HLA 
type is thus consistent with an archaic origin and the known 
propensity for HLA-B to evolve faster than HLA-A and HLA-
C (17, 18). 
Not knowing the haplotype phase, we examined all 
possible combinations of Denisovan HLA-A and HLA-C for 
their current distribution worldwide. All four combinations 
are present in Asia and Oceania, but absent from Sub-Saharan 
Africa, and uncommon in Europe (Fig. 2, C and D, and fig. 
S13). Genome-wide comparisons showed that modern and 
archaic non-African genomes share only ten long, deeply 
divergent haplotypes (3), which are all considerably shorter 
(100-160kb) than the ~1.3Mb HLA-A-C haplotype (Fig. 2A). 
Because modern HLA haplotypes diversify rapidly by 
recombination (17–19) it is improbable that the HLA-A-C 
haplotypes shared by modern humans and Denisovans were 
preserved on both lines since modern and Denisovan 
ancestors separated >250kya (~10,000 generations (4)). More 
likely is that modern humans acquired these haplotypes by 
recent introgression from Denisovans (note II.6 (11)). Both 
alternative haplotype pairs are common in Melanesians, 
reaching 20% frequency in Papua New Guinea (PNG), 
consistent with genome-wide assessment of Denisovan 
admixture in Melanesians (4). The current distribution of the 
Denisovan haplotypes (Fig. 2, C and D, and fig. S13) shows, 
however, that Denisovan admixture widely influenced the 
HLA system of Asians and Amerindians. 
Of the two Denisovan HLA-A alleles (Fig. 2B), A*02 is 
widespread in modern humans, whereas A*11 is 
characteristically found in Asians (Fig. 2E), reaching 50-60% 
frequency in PNG and China, less common in Europe, and 
absent from Africa (fig. S14). This distribution coupled with 
the sharing of long HLA-A-C haplotypes between Denisovans 
and modern Asians, particularly Papuans (fig. S13), indicates 
that Denisovan admixture minimally contributed the 
A*11:01-C*12 or A*11:01-C*15 haplotype to modern 
Asians. A*11:01, which is carried by both these archaic 
haplotypes, is by far the most common A*11 allele (12). 
Because HLA alleles evolve subtype diversity rapidly (17, 18) 
it is highly improbable that A*11:01 was preserved 
independently in Denisovan and modern humans throughout 
>250k years (4), as would be required if the Out-of-Africa 
migration contributed any significant amount of A*11. The 
more parsimonious interpretation is that all modern A*11 is 
derived from Denisovan A*11, and that following 
introgression it increased in frequency to ~20%, becoming 
almost as common in Asia as A*02 at ~24% (11). 
Denisovan HLA-C*15 and HLA-C*12:02 are also 
characteristic alleles of modern Asian populations (Fig. 2, F 
and G, and fig. S14). At high frequency in PNG, their 
distribution in continental Asia extends further west than 
A*11 does, and in Africa their frequencies are low. C*12:02 
and C*15 were formed before the Out-of-Africa migration 
(Fig. 2H and fig. S15) and exhibit much higher haplotype 
diversity in Asia than in Africa (fig. S16), contrasting with 
the usually higher African genetic diversity (20). These 
properties fit with C*12:02 and C*15 having been introduced 
to modern humans through admixture with Denisovans in 
west Asia, with later spreading to Africa (21, 22) (Fig. 1F and 
fig. S11 for C*15). Given our minimal sampling of the 
Denisovan population it is remarkable that C*15:05 and 
C*12:02 are the two modern HLA-C alleles in strongest LD 
with B*73 (Fig. 1E). Although B*73 was not carried by the 
Denisovan individual studied, the presence of these two 
associated HLA-C alleles provide strong circumstantial 
evidence that B*73 was passed from Denisovans to modern 
humans. 
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Genome-wide analysis showing three Vindija Neandertals 
exhibited limited genetic diversity (3) is reflected in our HLA 
analysis: each individual has the same HLA class I alleles 
(fig. S17). Because these HLA identities could not be the 
consequence of modern human DNA contamination of 
Neandertal samples, which is <1% (3), they indicate these 
individuals likely belonged to a small and isolated population 
(fig. S18). Clearly identified in each individual were HLA-
A*02, C*07:02, and C*16; pooling the three sequence data 
sets allowed identification of HLA-B*07, -B*51 and either 
HLA-A*26 or its close relative A*66 as the other alleles (Fig. 
3A). As done for the Denisovan, we examined all 
combinations of Neandertal HLA-A and HLA-C for their 
current distribution worldwide. All four combinations have 
highest frequencies in Eurasia and are absent in Africa (Fig. 
3, B and C, and fig. S19). Such conservation and distribution 
strongly support introgression of these haplotypes into 
modern humans by admixture with Neandertals in Eurasia. 
The Neandertal HLA-B and -C alleles were sufficiently 
resolved for us to study their distribution in modern human 
populations (fig. S20); their frequencies are high in Eurasia 
and low in Africa (Fig. 3, D to G, and fig. S21). Our 
simulations of HLA introgression predicted the increased 
frequency and haplotype diversity in Eurasia that we 
observed (Fig. 1 and fig. S11) and was particularly strong for 
B*51 and C*07:02 (fig. S22), and presence of such alleles in 
Africa was due to back-migrations. Thus, Neandertal 
admixture contributed B*07, B*51, C*07:02, and C*16:02-
bearing haplotypes to modern humans, and was likely the sole 
source of these allele groups. Unlike the distributions of 
Denisovan alleles, which center in Asia (Fig. 2, E to G), 
Neandertal alleles display broader distributions peaking in 
different regions of Eurasia (Fig. 3, D to G). 
Modern populations with substantial levels of archaic 
ancestry are predicted to have decreased LD (23). From 
analysis of HapMap populations (20), we find that HLA class 
I recombination rates are greater in Europeans (1.7-2.5 fold) 
and Asians (2.9-7.7 fold) than in Africans, consistent with 
their higher frequencies of archaic HLA class I alleles (Fig. 
4A). Enhanced LD decay correlates with presence of archaic 
alleles (Fig. 4B and fig. S23), and the strongest correlation 
was with HLA-A, for which the six haplotypes exhibiting 
enhanced LD decay are restricted to non-Africans. These 
haplotypes include A*24:02 and A*31:01 along with the four 
archaic allele groups we characterized (A*11, A*26 and two 
A*02 groups). A*24:02 and A*31:01 are common in non-
Africans and thus likely also introgressed from archaic to 
modern humans. From the combined frequencies of these six 
alleles, we estimate the putative archaic HLA-A ancestry to be 
>50% in Europe, >70% in Asia, and >95% in parts of PNG 
(Fig. 4, C and D). These estimates for HLA class I are much 
higher than the genome-wide estimates of introgression (1-
6%), showing how limited interbreeding with archaic humans 
has, in combination with natural selection, significantly 
shaped the HLA system in modern human populations outside 
of Africa. Our results demonstrate how highly polymorphic 
HLA genes can be sensitive probes of introgression, and we 
predict the same will apply to other polymorphic immune-
system genes, for example the killer-cell immunoglobulin-
like receptors (KIR) of NK cells. Present in the Denisovan 
genome (11), a candidate KIR for introgression is 
KIR3DS1*013 (Fig. 4E), rare in sub-Saharan Africans, but 
the most common KIR3DL1/S1 allele outside Africa (24). 
On migrating Out-of-Africa modern humans encountered 
archaic humans, residents of Eurasia for more than 200ky and 
having immune systems better adapted to local pathogens 
(25). Such adaptations almost certainly involved changes in 
HLA class I, as exemplified by the modern human 
populations who first colonized the Americas (17, 18). For 
small migrating populations, admixture with archaic humans 
could restore HLA diversity following population bottleneck, 
and also provide a rapid way to acquire new, advantageous 
HLA variants already adapted to local pathogens. For 
example, HLA-A*11, an abundant archaic allotype in modern 
Asian populations, provides T cell-mediated protection 
against some strains of Epstein-Barr virus (EBV) (26) and in 
combination with a peptide derived from EBV is one of only 
two HLA ligands for the KIR3DL2 NK cell receptor (27). 
HLA*A11 is also the strongest ligand for KIR2DS4 (28). 
Other prominent introgressed HLA class I are good KIR 
ligands. HLA-B*73 is one of only two HLA-B allotypes 
carrying the C1 epitope, the ligand for KIR2DL3 (29). 
Prominent in Amerindians, C*07:02 is a strong C1 ligand for 
KIR2DL2/3 and both B*51 and A*24 are strong Bw4 ligands 
for KIR3DL1 (30). Such properties suggest that adaptive 
introgression of these HLA alleles was driven by their role in 
controlling NK cells, lymphocytes essential for immune 
defense and reproduction (6). Conversely, adaptive 
introgression of HLA-A*26, -A*31, and -B*07, which are not 
KIR ligands, was likely driven by their role in T cell 
immunity. Adaptive introgression provides a mechanism for 
rapid evolution, a signature property of the extraordinarily 
plastic interactions between MHC class I ligands and 
lymphocyte receptors (6). 
References and Notes 
1. A. Gibbons, Science 331, 392 (2011). 
2. V. Yotova et al., Mol Biol Evol 28, 1957 (2011). 
3. R. E. Green et al., Science 328, 710 (2010). 
4. D. Reich et al., Nature 468, 1053 (2010). 
5. V. Castric, J. Bechsgaard, M. H. Schierup, X. Vekemans, 
PLoS Genet 4, e1000168 (2008). 
6. P. Parham, Nat. Rev. Immunol. 5, 201 (2005). 
7. K. Cao et al., Hum Immunol 62, 1009 (2001). 
8. P. Parham et al., Tissue Antigens 43, 302 (1994). 
  / www.sciencexpress.org / 25 August 2011 / Page 4 / 10.1126/science.1209202 
 
9. C. Vilches, R. de Pablo, M. J. Herrero, M. E. Moreno, M. 
Kreisler, Immunogenetics 40, 166 (1994). 
10. J. Robinson et al., Nucleic Acids Res 39, D1171 (2011). 
11. Materials and methods are available as supporting 
material on Science Online. 
12. F. F. Gonzalez-Galarza, S. Christmas, D. Middleton, A. 
R. Jones, Nucleic Acids Res 39, D913 (2011). 
13. C. Vilches, R. de Pablo, M. J. Herrero, M. E. Moreno, M. 
Kreisler, Immunogenetics 40, 313 (1994). 
14. D. M. Behar et al., Am J Hum Genet 82, 1130 (2008). 
15. O. Semino, A. S. Santachiara-Benerecetti, F. Falaschi, L. 
L. Cavalli-Sforza, P. A. Underhill, Am J Hum Genet 70, 
265 (2002). 
16. M. J. Jobin, J. L. Mountain, Bioinformatics 24, 2936 
(2008). 
17. M. P. Belich et al., Nature 357, 326 (1992). 
18. D. I. Watkins et al., Nature 357, 329 (1992). 
19. M. L. Petzl-Erler, R. Luz, V. S. Sotomaior, Tissue 
Antigens 41, 227 (1993). 
20. The International HapMap Consortium, Nature 437, 1299 
(2005). 
21. F. Cruciani et al., Am J Hum Genet 70, 1197 (2002). 
22. Y. Moodley et al., Science 323, 527 (2009). 
23. M. DeGiorgio, M. Jakobsson, N. A. Rosenberg, Proc Natl 
Acad Sci U S A 106, 16057 (2009). 
24. P. J. Norman et al., Nat Genet 39, 1092 (2007). 
25. A. Ferrer-Admetlla et al., J Immunol 181, 1315 (2008). 
26. P. O. de Campos-Lima et al., Science 260, 98 (1993). 
27. P. Hansasuta et al., Eur J Immunol 34, 1673 (2004). 
28. T. Graef et al., J Exp Med 206, 2557 (2009). 
29. A. K. Moesta et al., J Immunol 180, 3969 (2008). 
30. M. Yawata et al., Blood 112, 2369 (2008). 
31. P. I. de Bakker et al., Nat Genet 38, 1166 (2006). 
Acknowledgments: We thank individual investigators and 
the Bone Marrow Donors Worldwide (BMDW) 
organization for kindly providing HLA class I typing data, 
as well as bone marrow registries from Australia, Austria, 
Belgium, Canada, Cyprus, Czech Republic, France, 
Ireland, Israel, Italy, Lithuania, Norway, Poland, Portugal, 
Singapore, Spain, Sweden, Switzerland, Turkey, UK and 
USA for contributing typing data through BMDW. We 
thank E. Watkin for technical support. We are indebted to 
the large genome sequencing centers for early access to the 
gorilla genome data. We used sequence reads generated at 
the Wellcome Trust Sanger Institute as part of the gorilla 
reference genome sequencing project. These data can be 
obtained from the NCBI Trace Archive 
(www.ncbi.nlm.nih.gov/Traces). We also used reads 
generated by Washington University School of Medicine; 
these data were produced by the Genome Institute at 
Washington University School of Medicine in St. Louis 
and can be obtained from the NCBI Trace Archive 
(www.ncbi.nlm.nih.gov/Traces/). Funded by National 
Institutes of Health (NIH) grant AI031168, Yerkes Center 
base grant RR000165, National Science Foundation 
awards (CNS-0619926, TG-DBS100006), by federal funds 
from the National Cancer Institute, NIH (contract 
HHSN261200800001E), and by the Intramural Research 
Program of the NIH, National Cancer Institute, Center for 
Cancer Research. The content of this publication does not 
necessarily reflect the views or policies of the Department 
of Health and Human Services, nor does mention of trade 
names, commercial products, or organizations imply 
endorsement by the U.S. Government. Sequence data have 
been deposited in GenBank under accession numbers 
JF974053-70. 
 
Supporting Online Material 
www.sciencemag.org/cgi/content/full/science.1209202 
Materials and Methods 
Figs. S1 to S26 
References (32–87) 
1 June 2011; accepted 5 August 2011Published online 25 
August 2011; 10.1126/science.1209202 
Fig. 1. Modern humans acquired HLA-B*73 from archaic 
humans. (A) The B*73 haplotype contains segments most 
closely related to chimpanzee and gorilla MHC-B alleles 
(green) and flanking segments highly related to other HLA-B 
(blue) (brown segment is related to HLA-C) (fig. S4). (B) 
B*73’s divergent core has its roots in a gene duplication that 
occurred >16 million years ago (MYA). (left to right) MHC-B 
duplicated and diverged to form the MHC-BI and BII loci. 
One allele of BII recombined to the BI locus giving rise to the 
ancestor of B*73 and its gorilla and chimpanzee equivalents. 
B*73 is thus the only remnant in modern humans of a deeply 
divergent allelic lineage. §, mean and 95% credibility 
interval. (C to E) B*73:01 is predominantly found outside 
Africa (C) as is C*15:05 (D), which is strongly associated 
with B*73 in 3,676 individuals worldwide (E). Individuals 
with the B*73 haplotype were categorized on the basis of 
their geographic origin, and status of the most-commonly 
linked (C*15) and second-most commonly linked (C*12:02) 
HLA-C alleles (fig. S24). # includes Hispanic-Americans, ## 
includes African-Americans. (C and D) Scale bars give allele 
frequency (af) categories (top number, highest tick mark). (F) 
Archaic admixture (model ‘a’) or African origin (model ‘b’) 
could explain the distribution and association of B*73 with 
C*15:05; simulations favor the former (α = 0.01-0.001) (figs. 
S9 to S11) (11). The dotted box indicates the part of the 
models examined by simulation. 
Fig. 2. Effect of adaptive introgression of Denisovan HLA 
class I alleles on modern Asian and Oceanian populations. 
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(A) Simplified map of the HLA class I region showing the 
positions of the HLA-A, -B and -C genes. (B) Five of the six 
Denisovan HLA-A, -B and -C alleles are identical to modern 
counterparts. Shown at the left for each allele is the number 
of sequence reads (4) specific to that allele and their coverage 
of the ~3.5kb HLA class I gene. Center columns give the 
modern-human allele (HLA type) that has the lowest number 
of SNP mismatches to the Denisovan allele. The next most 
similar modern allele and the number of SNP differences are 
shown in the columns on the right. ¶, a recombinant allele 
with 5’ segments originating from B*40. §, the coding 
sequence is identical to C*15:05:02. (C and D) Show the 
worldwide distributions of the two possible Denisovan HLA-
A-C haplotype combinations. Both are present in modern 
Asians and Oceanians but absent from Sub-Saharan Africans. 
(E to G) The distribution of three Denisovan alleles: HLA-
A*11 (E), C*15 (F), and C*12:02 (G), in modern human 
populations shows they are common in Asians but absent or 
rare in Sub-Saharan Africans. (H) Estimation of divergence 
times shows that A*11, C*15 and C*12:02 were formed 
before the Out-of-Africa migration. Shown on the left are the 
alleles they diverged from, on the right are the divergence 
time estimates: median, mean, and range. 
Fig. 3. Effect of adaptive introgression of Neandertal HLA 
class I alleles on modern human populations. (A) All six 
Neandertal HLA-A, -B and -C alleles are identical to modern 
HLA class I alleles. Shown at the left for each allele is the 
number of allele-specific sequence reads (3) and their 
coverage of the ~3.5kb HLA gene. Center columns give the 
modern-human allele (HLA type) having the lowest number 
of SNP differences from the Neandertal allele. The next most 
similar modern allele and the number of SNP differences are 
shown in the columns on the right. §, includes additional rare 
alleles. (B and C) Show the worldwide distributions of the 
two possible Neandertal HLA-A-C haplotype combinations. 
Both are present in modern Eurasians, but absent from Sub-
Saharan Africans. (D to G) Distribution of four Neandertal 
alleles: HLA-B*07:02/03/06 (D), B*51:01/08 (E), C*07:02 
(F), and C*16:02 (G), in modern human populations. 
Fig. 4. Linkage disequilibrium (LD) decay patterns of modern 
HLA haplotypes identify putative archaic HLA alleles. (A) 
HLA class I recombination rates in Eurasia exceed those 
observed in Africa. We focused on the three intergenic 
regions between HLA-A, -B , and -C (leftmost column) in the 
four HapMap populations (center column) (20). 
Recombination rates were corrected for effective population 
size (11). (B) Enhanced HLA class I LD decay significantly 
correlates with archaic ancestry (α = 0.0042; (11)). Shown for 
each HapMap population are (top row) the number of distinct 
HLA-A alleles present and (second row) the number 
exhibiting enhanced LD decay (all allele-defining SNPs 
(r2>0.2) are within 500kb of HLA-A (31)). The allele names 
are listed (rows 3-8) and colored green when observed in 
archaic humans (Figs. 2 and 3) or associated with archaic-
origin haplotypes (fig. S25). HLA-B and -C are shown in fig. 
S23. --- absent in the population. (C) Predicted archaic 
ancestry at HLA-A (on the basis of the six alleles of panel (B)) 
for the four HapMap populations and six populations from 
PNG; for the latter mean and extreme values are given. (D 
and E) Worldwide distribution in modern human populations 
of putative archaic HLA-A alleles (D) and KIR3DS1*013, a 
putative archaic NK cell receptor (E). 
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Supporting Online Material 
Materials and Methods 
  
Part I. HLA-B*73 
 
I.1 Characterization of the HLA-B*73:01 haplotype and of a chimpanzee allele of 
the B*73 lineage. An Epstein-Barr virus-transformed B-cell line derived from a HLA-
B*73:01 donor was used as source of genomic DNA for the construction of a cosmid 
library, using the SuperCos 1 Cosmid Vector Kit (Stratagene, Santa Clara, CA) per 
manufacturer’s instructions. The library was screened with a 32P-labeled B*73:01 cDNA 
probe, and hybridizing clones analyzed by end-sequencing and targeted amplification of 
B*73:01 using primers B*73-Forward (5’-AACCGTCCTCCTGCTGCTC-3’) and B*73-
Reverse (5’-GCGACCACAGCTACGGTGA-3’). One cosmid of ~38kb, which contained 
the complete B*73:01 gene, flanked by ~27kb of DNA at the 5’ end and ~8kb at the 3’ 
end, was selected for shotgun sequencing (TOPO Shotgun Subcloning Kit, Invitrogen, 
Carlsbad, CA). 
Genomic DNA from a panel of 95 chimpanzees was typed by PCR specific for alleles of 
the B*73 lineage (MHC-BII lineage). PCR primers were TypeF (5’-
GCTTAGATGAACATGAAAAGATAG-3’) and TypeR (5’-
TAGTTGATTGACATGTGGATTA-3’). 
 
I.2 Characterization of extended MHC-B gene sequences in hominoids. To compare 
the region of the HLA-B*73:01 haplotype that is directly derived from the second lineage 
of MHC-B alleles (MHC-BII), a region of ~8.5kb around the MHC-B gene was 
characterized in several common chimpanzees and gorillas, and one bonobo. Primers 
8.5F (5’-GTCAGGACAAGAGGAACAGAGAAAC-3’) and 8.5R (5’-
GTTCAGCACCAAGATCACTAGAACC-3’) were used in chimpanzees and 8.5GorF 
(5’-GTCAGGAWAAGAGGAACAGAGAAAC-3’) and 8.5R in gorillas. PCR products 
were isolated by gel electrophoresis, cloned into the pcr2.1-TOPO vector (Invitrogen) 
and clones from three independent amplifications were sequenced directly with specific 
overlapping primers.  
In addition to these sequences, we used BAC clones to characterize a ~38kb gorilla 
haplotype carrying Gogo-B*06:01, an ~8.5kb orangutan region carrying Popy-B*03:02, 
and the Popy-C*02:02 gene. BAC clones carrying these genes were obtained by 
screening the NCBI trace archive database (http://www.ncbi.nlm.nih.gov/Traces/) for 
MHC-B gene-containing BAC clones. Clones 498J12 and 308J7 were isolated from the 
CHORI-277 gorilla library, together with clones 253H24 and 97B06 from the CHORI-
276 orangutan library. Clones were shotgun-sequenced using a Genome Sequencer FLX 
(Roche/ 454 Life Sciences); samples were prepared and sequenced using the GS 
Titanium reagents per manufacturer's instructions. The ~6,900 reads we generated were 
assembled using MIRA (32) and the assembly edited with the GAP4 program of the 
STADEN package (33). The assembly was then supplemented by 63 sequence reads 
generated at the Wellcome Trust Sanger Institute as part of the gorilla reference genome 
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sequencing project. These data can be obtained from the NCBI Trace Archive 
(http://www.ncbi.nlm.nih.gov/Traces/). The assembly was further supplemented by three 
sequence reads generated by Washington University School of Medicine; these data were 
produced by the Genome Institute at Washington University School of Medicine in St. 
Louis and can be obtained from the NCBI Trace Archive 
(http://www.ncbi.nlm.nih.gov/Traces/). These 66 reads were obtained by BLAST search 
(34), using as probes the genomic segments with low coverage in our assembly. Those 
sequence reads that displayed a well-supported mismatch (i.e. a difference at a position 
with good quality in both directions) with sequence reads in our assembly, likely 
represented the other MHC-B haplotype and were not used. Finishing was performed by 
PCR amplifications on the two BAC clones and Sanger sequencing of the PCR products. 
The same approach was used for the orangutan analysis, but sequence reads were from 
the Washington University Genome Sequencing Center and Baylor College of Medicine 
(orangutan genome project (35)). The names of the animals used for the characterization 
of these sequences are given in figure S2. 
 
I.3 Sequencing and accession numbers. Sequencing of the B*73 cosmid clone, the 
8.5kb extended chimpanzee and gorilla MHC-B genes, as well as finishing for the gorilla 
and orangutan genomic segments characterized from BAC clones, used an ABI377 DNA 
sequencer (Applied Biosystems, Carlsbad, CA), a CEQ2000XL (Beckman), and McLab 
(South San Francisco, CA). Sequences were assembled with the STADEN package (33), 
and finished to high-quality standard: each base pair of the final assembly was minimally 
covered by three sequences representing two different templates and had a quality score 
>40-80 (error rate <1/10
4
-1/10
8
). Completed sequences were deposited in GenBank under 
accession numbers JF974053-70.  
 
I.4 Sequence analysis of the HLA-B*73:01 haplotype. Haplotype and extended gene 
sequences were aligned with MAFFT (36) and corrected manually. Insertions of >100bp 
and unique to one sequence, to MHC-C or to macaque MHC-B sequences were excluded. 
The pattern of historical recombination in the region was investigated with the program 
RDP (37) and confirmed by Neighbor-Joining (NJ) analyses with MEGA4 (38) and 
alignment inspection. Following this analysis, the alignment was divided into 14 
segments, which were each analyzed by three phylogenetic methods: maximum-
likelihood (ML), NJ and parsimony. NJ analysis was performed with MEGA4 (38) using 
the Tamura-Nei method with 500 replicates. PAUP*4.0b10 (39) and the tree bisection-
reconnection branch swapping algorithm were used for parsimony analyses with 500 
replicates and heuristic search. ML analyses were performed with RAXML7 (40) under 
the GTR+CAT model with 500 replicates (rapid bootstrapping). 
 
I.5 MHC-BI-BII divergence time analysis. Mean and 95% credibility interval values for 
the divergence time between the MHC-BI and MHC-BII lineages were estimated using a 
Bayesian approach with the program MCMCTREE (v4.4c) from the PAML package 
(41). Analysis was conducted with an independent-rates molecular clock, the HKY85+Γ 
model of nucleotide substitution, on a ~4.4kb segment located 5’ of the MHC-B gene 
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(segment #5 of figure S3), and used a ML tree topology (fig. S3). Several fossil 
calibration points were used for the following speciation events: human-chimpanzee, 6.5-
10 million years ago (MYA) (42); gorilla-orangutan, >10MYA (43, 44); human-gorilla, 
>10MYA (45); human-Old World monkey 23-33.9MYA (42).  
Priors for the transition/transversion rate ratio () and the shape parameter for gamma 
rates () were set as follows: means were estimated using the BASEML program of the 
PAML package (41) and SD were set so that prior SD would be about two times the 
posterior SD. Priors for the overall rate parameter (μ) and for the parameter 2, which 
specifies how variable the rates are across branches, were set as follows: prior means 
were set according to the posterior means and prior SD were set to be about four times 
the posterior SD. Step lengths used in the MCMC algorithm were set so that acceptance 
proportions were all in the interval 0.2-0.4. Three independent runs were conducted and 
in each case produced similar results.  
 
I.6 Distribution of B*73 and C*15:05. Allele frequencies for B*73 and C*15:05 were 
obtained from the Allele Frequency Net Database (12). Distribution maps were generated 
using the GMT software package (46) and a previously developed script (47). Only 
studies of more than 40 individuals were included: either anthropology studies or studies 
documenting the donors as unrelated. Data from bone marrow registries were excluded 
(unless frequencies were established on a group of randomly-selected donors), as well as 
data from admixed populations (for example African-Americans) or recent migrant 
populations for which the geographical origin was not well defined (for example ‘USA 
Asian’). 
 
I.7 Estimation of the extent of linkage between B*73:01 and C*15:05. HLA-C*15:05 
was discovered as a novel HLA-C allele on a haplotype with HLA-B*73:01 (13). To 
determine how frequently C*15:05 and B*73 are on the same haplotype, we obtained 
data from anthropology studies and bone marrow registries (fig. S7). The former were 
directly obtained from the authors, while the latter were obtained with permission from 
the Bone Marrow Donors Worldwide (BMDW) and the National Marrow Donor Program 
(NMDP) organizations.  
HLA-B and -C genotyping was performed to confirm the B*73 type of an African 
American B*73 donor using LABType
®
 SSO reagents (One Lambda Inc, Canoga Park, 
CA) and detection by a Luminex 100 instrument (Luminex corp, Austin TX). High-
resolution HLA-C typing was performed for five B*73 donors from the Anthony Nolan 
Trust using LABType® reagents. Eight unrelated B*73 donors from Ankara (Turkey) 
were genotyped for HLA-B and -C using Lifecodes typing kits (Tepnel Lifecodes, 
Stamford, CT). Six donors from Kenya and Tanzania were sequence-based genotyped for 
HLA-B and -C, as previously described (48). A further 120 B*73 donors from the 
Canadian OneMatch Stem Cell and Marrow Network were retyped at high resolution for 
HLA-B and -C using the AlleleSEQR HLA sequence-based typing (SBT) method (Atria 
Genetics, South San Francisco, CA), with additional tests using LABType
®
 SSO 
reagents. 
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Because bone marrow registry data include low-resolution HLA-C typing, for the LD 
analysis (fig. S7) the C*15 alleles with no defined subtype were allocated to the C*15:05 
or C*15:not05 groups based on the C*15:05/C*15:not05 ratio, on a region-by-region 
basis. This approach allowed us to have an ‘Estimated C*15:05’ category for each 
geographical region. 
HLA-C-B haplotype structures were determined for 46 B*73
+
 individuals lacking C*15 
using an implementation of the Expectation Maximization algorithm that accepts allelic 
ambiguities as inputs (49). Due to the small sample size, only C-B haplotypes containing 
B*73:01 with count >2 are provided. 
 
I.8 Haplotype data for population simulations. The frequencies of B*73 and C*15:05 
used in simulations were obtained as indicated above (section I.6), except that data for a 
few additional African populations were obtained from dbMHC (50) (lacking B*73 and 
C*15:05, these populations were not included in the distribution maps); data are 
summarized in figure S9. Because anthropology studies commonly investigate a single 
locus (e.g. HLA-B or HLA-C), allele frequencies for both B*73 and C*15:05 are not 
always available from the same set of individuals. Thus, to prepare haplotype data for 
population simulation we used three steps to set the linkage between the B and C alleles 
according to the linkage data estimated from anthropology studies that investigated both 
loci and data from bone marrow donors (fig. S7). First, the total number of haplotypes 
and the number of B*73 haplotypes in the simulation were set to match the data observed 
in populations with HLA-B genotyping in west Asia or in Africa (fig. S9A). Second, the 
number of C*15:05 haplotypes in these HLA-B genotyped populations was calculated 
using the frequencies observed in HLA-C genotyped populations (fig. S9B), on a region-
by-region basis. Finally, the extent of linkage between B*73 and C*15:05 was set 
according to linkage data summarized in figure S7 (on a region-by-region basis), but 
because of the heterogeneity in typing data and the possibility that some bone marrow 
donors represent related donors, we investigated nine models of linkage between B*73 
and C*15:05 (fig. S10). 
 
I.9 Population simulations. We compared two alternative models to explain how the 
B*73-C*15:05 haplotypes were formed and propagated in western Asia and in Africa: a 
model of archaic admixture (Model ‘a’) and a model of African ancestry (Model ‘b’) 
(Fig. 1). Comparison of the models was conducted with the rejection-based approximate 
Bayesian inference and hypothesis testing software REJECTOR (16). In a first phase, 
simulated data were generated for each model using a coalescent simulation (51) based 
on the population demographic events, parameters (see Fig. 1 and section I.10) and 
haplotype data (fig. S10) supplied for each model. In a second phase, the simulated data 
were compared to the observed data and either ‘accepted’ or ‘rejected’; this process was 
repeated several million times. 
To compare simulated and observed data, two summary statistics were used: ‘Derived 
Fraction’, which is the proportion of derived alleles present in the extant populations, and 
‘LD’, the linkage disequilibrium measured as r2 (52). For each statistic, when the 
simulated values matched the observed values (with some tolerance) in both western Asia 
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and Africa, the iteration was considered a ‘single accept’; if an iteration produced ‘single 
accepts’ for both summary statistics, it was treated as a ‘double accept’. Because of the 
generally low frequencies of B*73 and C*15:05, the tolerance for the ‘Derived Fraction’ 
statistic was set at 99% (i.e. a range of 0.01-1.99% is tolerated for an observed allele 
frequency of 1%) and at 50% for the ‘LD’ statistic. A test was also conducted with these 
two tolerance values halved (fig. S11B). 
One model was considered to be significantly favored by the simulations when it gained 
>19 times the number of double accepts achieved by the alternative model (>95:5 ratio, 
5% significance level). 
 
I.10 Parameters for population simulation. For both models a and b, population sizes 
were considered under exponential growth with effective population sizes and growth 
rates derived from Pilkington et al. (53); recombination was set a 0.44cM/Mb (31). The 
Out-of-Africa migration was set at 3,375 generations ago (~67.5kya), without affecting 
the size of the African population, and a back-migration into Africa was set so that 10% 
of African ancestry traced back to western Asia, 500 generations ago (~10kya) (21). In 
both models, C*15:05 was formed in western Asia 3,250 generations ago (~65kya), so 
that the two models would only differ regarding where and when B*73 emerged: in 
western Asia 2,500 generations ago (~50kya) for model ‘a’ and in Africa 5,250 
generations ago (~105kya) for model ‘b’. 
 
I.11 Note: explanation of HLA nomenclature. HLA alleles are distinguished by a 
rational nomenclature (54) in which the name of the gene is followed by up to four sets of 
digits separated by colons. The digits before the first colon distinguish groups of alleles 
that roughly correspond to the serological types first used to define HLA class I 
polymorphisms. The next set of digits distinguishes subtypes that differ in their amino-
acid sequences. Subsequent sets of digits distinguish alleles that differ by synonymous 
(third set) or intronic (fourth set) differences.  
 
I.12 Note: study approval. This study was approved by the Stanford University 
administrative panels on human subjects in medical research and laboratory animal care.  
 
Part II. Analysis of the HLA class I content of the Denisova and Neandertal 
genomes 
 
II.1 Isolation and re-mapping of the Neandertal and Denisovan HLA class I 
sequence reads. To investigate Denisovan (4) and Neandertal (3) HLA class I content, 
we downloaded from the UCSC Genome Browser website (http://genome.ucsc.edu) all 
sequence reads previously assembled to the human (hg18) and chimpanzee (panTro2) 
genomes. Using SAMTOOLS 0.1.12a (55), we extracted all reads within the coordinates 
chr6:28,810,000-33,500,000 of hg18 (127,562 reads) and chr6:30,978,159-34,115,302 of 
panTro2 (185,092 reads), corresponding to an interval including TRIM27, KIFC1 and all 
classical HLA/MHC loci.  
Re-mapping was conducted using a set of HLA-A,-B,-C,-E,-F,-G reference sequences 
(one sequence for each subtype), as well as sequences for the pseudogenes HLA-H,-J,-K,-
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L,-P,-S,-T,-U,-V,-W,-X,-Y (10). Assembly of HLA class I from the Denisovan genome and 
the three Neandertal genomes was performed using MIRA (32). The contigs were 
investigated and edited using GAP4 of the STADEN package (33); only a single copy of 
the reads mapped both in the hg18 and panTro2 MHC regions was kept. 
The Neandertal sequences presented a special problem for alignment because of errors 
characteristic of ancient DNA (3, 56), namely a high rate of C to T transitions at the 5’ 
end of reads and an equally high rate of G to A transitions at the 3’ end. Identifying 
relevant reads by sequence similarity searching was hampered by these ancient DNA 
associated base misincorporations. The Denisova sequence data suffered much less from 
this problem, because an enzymatic pre-treatment of the DNA (57) largely corrected the 
errors. To generate a more comprehensive list of relevant Neandertal reads, we re-
mapped all the primary Neandertal data against the reference panel of HLA class I 
sequences using a custom mapper, mia, (available from the authors upon request) with 
the following command-line parameters: -k 12 –N 500 –S 100. This program 
incorporates the special position-specific error profile of these data into its scoring 
scheme for identifying and aligning sequences. Because it performs a full Smith-
Waterman alignment this program is not hampered by insertion-deletion differences that 
can erode the sensitivity of heuristic aligners. With this approach 164 additional 
Neandertal sequences were identified from the original mapping to human and 
chimpanzee genomes. 
 
II.2 Characterization of the Denisovan and Neandertal HLA-A/-B/-C content. Locus-
specific screen: following re-mapping, we screened the assemblies to ensure all reads 
associated with HLA-A,-B, or -C were specific to that locus: each sequence read was 
compared to the reference HLA class I dataset (10) and any read shared with another 
locus was discarded. For reads having substitutions absent from the reference dataset, 
comparison to a larger dataset including all coding sequences (10) was conducted. If this 
approach failed to identify a sequence with the same SNP, BLAST was used (34) to 
examine MHC class I in other species. SNPs not represented in the known human and 
non-human primate MHC class I sequences (more than 6,800 sequences (10, 58)) were 
attributed to misincorporation errors made during PCR amplification of ancient DNA and 
ignored. 
Allele-specific screen: HLA-A,-B, and -C allele content was determined for each archaic 
individual by comparing all locus-specific sequences to the reference panel of HLA class 
I sequences. For Neandertal HLA-A/B/C and Denisovan HLA-A/C, this analysis allowed 
the sequences to be split in three groups: sequences from the first allele, sequences from 
the second allele, and sequences that could come from either allele (which were 
discarded). For Denisovan HLA-B, at least one allele was novel, and to associate several 
reads to one allele or the other we used a parsimony approach to minimize differences 
with modern sequences (fig. S12). 
The allele-specific sequences obtained for each gene and archaic human genome were 
compared to genomic and cDNA sequences from the corresponding gene of modern 
humans through pairwise comparisons, using MEGA4 (38). This analysis allowed a first 
assessment of Neandertal and Denisovan HLA-A/B/C content. This information was used 
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to design a second and more specific re-mapping to ensure capture of all the relevant 
sequence reads. For this reanalysis the initial set of reference HLA-A/B/C genomic 
sequences, which included one sequence for each of the allele groups, was increased to 
include all the available genomic sequences for the allele groups that we had determined 
were present in the Denisovan/Neandertal genomes. Following this remapping we used 
the same locus and allele-specific determination to refine the allele string. 
 
II.3 Distribution and diversity of Denisovan/Neandertal alleles and haplotypes. 
Allele frequency data and distribution were investigated as described above (Section I.6). 
For the study of haplotype distributions, data were also obtained from dbMHC (50), and 
from Melanesian populations (59). HLA genotype phasing for the Melanesian populations 
was performed using PHASE 2.1 (60, 61).  
Analysis of the diversity of HLA haplotypes carrying alleles of Denisovan/Neandertal 
origin was conducted using the same data sources as described above (12, 50). Because 
low-frequency haplotypes are not always reported in these databases, to investigate 
haplotype structures in Africa (where haplotypes carrying Denisovan HLA-C alleles are 
rare) we used data from a panel of ~2,400 African-American donors, for whom the 
haplotypes are well defined (62). 
 
II.4 Divergence time analyses for HLA-A*11, C*12:02 and C*15. Estimation of the 
emergence times of A*11, C*12:02 and C*15 was performed as described for the B*73 
lineage (section I.5); specifics such as the datasets used or differences with the analysis 
described in section I.5 are given below for each allele. The phylogenetic tree topologies 
used for the divergence time analyses and presented in figure S15 were obtained using 
the methods described in section I.4.  
For HLA-A*11, a dataset of ~2.2kb representing the genomic segment between intron 3 
and the 3’UTR of HLA-A was used, because this segment has not been a target for 
recombination (63). Divergence time analysis was conducted as indicated in section I.5, 
except that prior SD for the overall rate parameter (μ) and for the parameter 2 were set 
to be about two times the posterior SD.  
For C*15, we used a dataset of ~3kb representing the complete HLA-C gene, except for 
two recombinant segments in exon 3 (64). For C*12:02, we used a dataset of ~2.6kb 
representing a partial HLA-C gene sequence, with exon 2 and part of exon 3 excluded due 
to the presence of two gene conversion events. To avoid recombinants, a minimum 
number of sequences was used in these analyses. Divergence time analyses were 
conducted as described in section I.5, except that prior SD for the overall rate parameter 
(μ) was set to be about twice the posterior SD. The mean and SD priors for the parameter 
2 were also set to one divided by the root age (65), and the SD for the shape parameter 
for gamma rates () was set to the mean value. In both analyses, the root of the tree 
corresponds to the separation between humans and orangutans; in addition to a minimum 
bound of 10MYA (43, 44), a maximum bound of 18MYA was used to reflect the 
probable separation of orangutans from human/African apes after the African continent 
became combined with Eurasia (66). 
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II.5 Frequency of HLA-A*02, A*11 and A*24 in Asia. To assess the overall 
frequencies of HLA-A*02, A*11 and A*24 in Asia, we obtained HLA frequency data for 
93 populations from 20 Asian countries representing >91% of the population of Asia. 
Frequencies in each country were defined as the median value for all considered 
populations. Using these median frequencies and the population size of each country 
(obtained from the Population Reference Bureau website, http://www.prb.or), we 
estimated the number of A*02, A*11 and A*24 alleles in each country and, by integrating 
over all Asia, obtained the average frequency. HLA frequencies were obtained as 
indicated in section I.6, with one exception to avoid sampling bias. For Taiwan, data from 
aborigine populations was not included, as they represent only ~2% of the population of 
the country but have been extensively sampled and studied. 
 
II.6 Note: Long and ancient haplotypes shared between archaic and modern non-
Africans are the products of archaic admixture. Over time recombination breaks 
haplotypic associations, so that the longer two populations have been separated the 
shorter their shared haplotypes become. Consistent with this thesis, Green et al. (3) found 
in a genome-wide scan across 50kb windows only 13 regions for which there is a much 
deeper coalescence time separating non-African haplotypes than African haplotypes. The 
presence of these 13 long haplotypes could be explained by archaic admixture in non-
Africans. For 10 of these regions, Neandertal sequences matched the deep clade unique to 
non-Africans, suggesting that when this haplotype configuration is observed, it is often 
the result of Neandertal admixture (3). Thus, in the genomes of non-Africans, deeply 
divergent haplotypes of more than >50kb deriving from African ancestry (as opposed to 
admixture) are seen to be very uncommon (3).  
The Denisovan and Neandertal HLA haplotypes we characterized in this study follow the 
same pattern but have more dramatic features. For example, the haplotype formed by 
A*11 and either C*12:02 or C*15 is shared by Denisovans and modern Asian and 
Oceanian populations. This haplotype is more than eight times the size of the longest 
shared haplotype observed by Green et al in the genome-wide study (~1.3Mb vs ~160kb, 
respectively) (3). This A*11-C*12:02 or A*11-C*15 haplotype does not exist in Africa 
but carries allele groups whose formation predates the separation between archaic and 
modern humans. Similarly and more specifically, studies of isolated Amerindian 
populations show that HLA class I alleles are rapidly diversified by recombination (17, 
18) so that long-term (>250ky) conservation of allele sequences or haplotype structures is 
not an expected feature of HLA class I evolution, despite strong balancing selection (67). 
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Part III. HLA class I recombination rates and LD decay in four reference 
populations  
  
III.1 Estimation of HLA class I recombination rates. Recombination rates were 
estimated in four populations (YRI, Yoruba (Nigeria); CEU, Europeans from Utah; CHB, 
Han Chinese; JPT, Japanese) using high-resolution phased SNP data (31). Three genomic 
intervals were analyzed for each population, HLA-A-B, A-C and C-B. For the HLA-C-B 
interval all SNP between the two loci were used (89-101 SNP; ~1SNP/kb), while for the 
HLA-A-C and A-B intervals, one of every five SNP was used (299-321 SNPS; 
~1SNP/4.5kb). For each run of PHASE 2.1 (68, 69), we used the general model for 
recombination rate (-MR0), and sampling was performed for 500 iterations (thinning 
interval of 1) after a burn-in phase of 500 iterations; three independent runs were 
conducted for each population and interval. The run producing the best goodness-of-fit 
measure was retained (fig. S26). The population recombination rate () for each interval 
was then converted to cM/Mb using an effective population size of 7,500 for the African 
population and 3,100 for the non-African populations (70).  
 
III.2 Characterization of haplotypes with rapid LD decay. High-resolution 
genotyping has identified SNP markers that correlate with individual HLA alleles (31). 
We defined haplotypes with rapid LD decay as those where all the HLA-identifying 
SNPs (r
2
>0.2) occurred within 500kb of that HLA locus. This analysis was performed 
separately for each locus and population. 
 
III.3 Correlation between haplotypes with rapid LD decay and archaic alleles. The 
correlation between archaic alleles and alleles defining haplotypes with rapid LD decay 
was studied using a binomial distribution: considering =(0,1,2,…,n), k, p=(X=k)= 
nCk * p
k 
*
 
q
n–k
.  
This indicates for example that under a random distribution it is unlikely to have more 
than 28 of the 100 archaic alleles defining haplotypes with rapid LD decay, as the latter 
only represents 49 of the 231 haplotypes (=0.05); so the fact that 33 of the 100 archaic 
alleles define haplotypes with rapid LD decay indicates a biased distribution ( =0.0042). 
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Part IV. KIR3DL1/S1 in the Denisova genome  
 
To investigate the KIR3DL1/S1 content of the Denisova genome (4), we used the 
approach detailed in section II.1 for the HLA class I genes: all reads that had been 
mapped to the KIR locus of human (chr19:59,920,000-60,075,000) and chimpanzee 
(chr19:60,452,452-60,582,180) reference genomes were extracted and remapped to the 
variant KIR genomic sequences (71). KIR3DL1 and KIR3DS1 are alleles of the 
KIR3DL1/S1 gene (24, 58). There were 405 reads that mapped exclusively to 3DL1/S1, 
66 of these reads identified 3DS1 (3DS1*013 closest known allele) and 76 identified 
3DL1 (3DL1*005 closest known allele). Demonstrating two alleles were present, 41 
nucleotide positions were heterozygous for 3DL1 and 3DS1 and these occurred 
throughout the 15kb genomic sequence of 3DL1/S1.  
Allele frequencies of 3DS1*013 were obtained from 117 populations (12). Distribution 
maps were generated using the GMT software package (46), as indicated in section I.6. 
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Figure S1
Simplified map of the HLA class I region
Telomere Centromere
HLA-A HLA-C HLA-B
85kb
~1.3Mb
~1.4Mb
Chr:6p21.3
Supporting Figures
Fig. S1. Simplified map of the HLA class I region. Schematic representation of the 
location and distances between the HLA-A, HLA-B and HLA-C loci. HLA or human 
leukocyte antigen is the name given to the Major Histocompatibility Complex (MHC) in 
humans. HLA alleles are distinguished by a rational nomenclature (54) in which the name 
of the gene is followed by up to four sets of digits separated by colons. The digits before 
the first colon distinguish groups of alleles that roughly correspond to the serological 
types first used to define HLA class I polymorphisms. The next set of digits distinguishes 
subtypes that differ in their amino-acid sequences. Subsequent sets of digits distinguish 
alleles that differ by synonymous (third set) or intronic (fourth set) differences.  
Figure S2
Characterization of extended MHC-B gene sequences in hominoids
MHC-B
Species Name  allele
*05:01
*09:01
Miss Eve *18:01
Phineas *24:01
*36:01
*38:01
Tank *03:01
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Gorilla
Common 
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Chimpanzee Allele of the B*73 lineage Source
Cheeta Patr-B*17:01 Sequencing
Leslie Patr-B*17:01 Sequencing
Lindsey Patr-B*17:01 Filiation
Fiona Patr-B*17:01 Filiation
Ericka Patr-B*17:01 Sequencing
A
B
Fig. S2. Characterization of extended MHC-B gene sequences in hominoids. (A) 
Chimpanzees, gorillas and orangutans from whom MHC-B extended gene or haplotype 
sequences were characterized. These sequences were named according to the MHC-B 
allele sequences they contain (IPD-MHC Database (58)). #, sequence determined from 
BAC DNA. (B) Patr-B*17:01 is a chimpanzee allele of the B*73 lineage (MHC-BII). 
Five chimpanzees from a panel of 95 tested were positive for B*73 lineage-specific PCR 
amplification. Sequencing or pedigree typing analysis showed all five individuals carried 
Patr-B*17:01. Patr-B*17:01 from Cheeta and Leslie was sequenced in this study. 
Lindsey and Fiona inherited Patr-B*17:01 from their mother, Leslie, and the sequence of 
Patr-B*17:01 from Ericka was determined previously (72). 
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Phylogenetic analysis of the segments forming the HLA-B*73:01 haplotype
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Fig. S3. Phylogenetic analysis of the segments forming the HLA-B*73:01 haplotype. (A-Q) Shown 
are phylogenetic reconstructions performed on each of 14 genomic segments (A-I, K-P). In blue at 
the top of each panel is shown the segment number (corresponds to the segments shown in panels 
(J, Q)) and its size. Analysis was performed using Maximum-Likelihood (ML), Neighbor-Joining 
(NJ) and parsimony with NJ tree topologies used for the display (midpoint rooting). Circles at 
nodes indicate strong (black) or moderate (grey) phylogenetic support, where bootstrap 
proportions from the three methods are ≥80% or ≥60%, respectively. Otherwise, bootstrap values 
are indicated when at least two methods gave ≥50% support (from top to bottom: NJ, parsimony, 
ML). To simplify the display some groups of MHC-B sequences were collapsed as indicated by 
black triangles: the number of sequences is given in parentheses together with the species 
composing the group (H, human; C, chimpanzees; G, gorilla; O, orangutan). Patr, Pan troglodytes; 
Papa, Pan paniscus; Gogo, Gorilla gorilla; Popy, Pongo pygmaeus; Mamu, Macaca mulatta.
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Figure S4
HLA-B*73 is the only remnant in modern humans of a deeply divergent allelic lineage
1 2 3 4 5 6 6/7 7 8 9 10 13 14
HLA-B*73:01 M(-21) C1
Patr-B*17:01 --- --- --- --- I(-21) C1 --- ---
Gogo-B*06:01 M(-21) C1
HLA-B*07:02 M(-21)
HLA-B*08:01 M(-21)
# #
HLA-B*14 /*38 /*39/*42/*48 --- --- --- --- --- M(-21) --- ---
HLA-B*67 --- --- --- --- --- M(-21) C1 --- ---
HLA-B*44:03/*50:01 T(-21)
#
Patr-B*01 /*03/*09/*18, Gogo-B*02/*03/*04 --- --- --- --- T(-21) --- ---
Patr-B*04 --- --- --- --- T(-21) C1 --- ---
Other MHC-B sequences --- --- --- --- --- T(-21) --- ---
Gogo-B*07 --- --- --- --- M(-21) C1 --- ---
HLA-C*17:01 --- --- --- --- --- M(-21) --- ---
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Fig. S4. HLA-B*73 is the only remnant in modern humans of a deeply divergent allelic lineage. (A) 
Phylogenetic analyses (fig. S3) show the B*73 haplotype contains segments most closely related to 
chimpanzee and gorilla MHC-B alleles (green) and flanking segments highly related to other HLA-B (blue) 
(brown segment is related to HLA-C). (B) Sequences with segments equivalent to those of B*73:01. Some 
human alleles acquired B*73:01 segments by recombination. 'M(-21)' and 'C1' are functional 
characteristics in the leader peptide and a1 domain, respectively. Presence of methionine at position -21 
ensures the HLA-B leader peptide is processed and bound to HLA-E, a ligand for CD94:NKG2 natural 
killer (NK) cell receptors (73). M(-21) is associated with MHC-BII but not with the main lineage of MHC-
B sequences (MHC-BI). Additionally, MHC-BII molecules have the C1 epitope (formed by valine 76 and 
asparagine 80 in the a1 domain) which engages the KIR2DL2/3 NK cell receptors (74); in contrast a 
minority of MHC-BI molecules have C1 (75). ---, no sequence. #, complete sequence. (C) Model to explain 
how the sequence and functional divergence of B*73 emerged and was maintained, despite the high level 
of recombination at MHC-B. B*73's divergent core was formed >16 million years ago (MYA), suggesting 
this divergence is linked to the MHC-B gene duplications that occurred in early hominoids (76, 77). 
Accordingly, following duplication and divergence of MHC-BI and BII, one allele of BII recombined to the 
BI locus giving rise to the ancestor of B*73 and its gorilla and chimpanzee equivalents. Sequence 
divergence likely reduced intra-locus recombination of BI-BII lineages (red arrow) comparing to the high 
levels of BI-BI recombination (blue arrow), thus contributing to the long-term structural conservation of 
the MHC-BII allele at the MHC-BI locus. §, mean and 95% credibility interval.
Figure S5
Diversity of the HLA-B allele groups
HLA-B 
allele 
group
Number of 
specific HLA 
allotypes
Notes
B*07 124
B*08 69
B*13 46
B*14 21
B*15 221
B*18 59
B*27 79
B*35 160
B*37 28
B*38 27
B*39 63
B*40 162
B*41 18
B*42 16
B*44 127
B*45 13
B*46 27
B*47 8
B*48 25
B*49 16
B*50 13
B*51 109
B*52 23
B*53 24
B*54 24
B*55 49
B*56 31
B*57 43
B*58 33
B*59 5
B*67 3
B*73 2 Second allotype: single observation
B*78 7
B*81 5
B*82 3
B*83 1 Uncommon recombinant
Fig. S5. Diversity of the HLA-B allele groups. The number of specific allotypes is given 
for each of the 36 HLA-B allele groups (from the IMGT-HLA Database, release 3.3.0 
(10)). B*73:02 was identified in one person and is possibly resulting from mutation in 
that individual. 
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Models for the distribution of HLA-B*73
D
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4.0
3.0
2.0
1.0
0.0
4.5
af
(%)
4.6
4.0
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2.0
1.0
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HLA-B*73:01 (Model 3)
af
(%)
Population Freq (%) n
Parsi 4.90 91
Israel Jews 2.30 146
United Arab Emirates 2.00 373
Cameroon Beti 1.10 174
Georgia Tibilisi 0.90 109
Bulgaria 0.90 55
Morocco Casablanca 0.90 100
Burkina Faso Mossi 0.90 53
Russia Tuva 0.80 169
Oman 0.80 118
Albania 0.60 160
Cameroon Bamileke 0.60 77
Mongolia Khalkha 0.50 200
Pakistan Pathan 0.50 100
Iran Baloch 0.50 100
Tanzania Dodoma Kongwa 0.50 212
Israel Arab Druze 0.50 101
Algeria 0.50 106
Saudi Arabia 0.40 383
Turkey 0.40 142
Bangladesh Dhaka Bangalee 0.30 141
Jordan Amman 0.30 146
Uganda Kampala 0.30 175
Kenya Nandi 0.20 240
Kenya Luo 0.20 265
Zimbabwe Harare Shona 0.20 230
Rwanda 0.20 280
Greece 0.20 246
Macedonia 0.20 216
Fig. S6. Models for the distribution of HLA-B*73. (A-D) Shown is the distribution of B*73 (A-C) and 
the B*73:01 allele frequency of all populations with B*73 (D). Because of uncertainty in the ancient 
geographical location of Parsis, the population with the highest B*73 frequency (12, 78) (D), we 
considered three models for the distribution of B*73 (A-C). While some Parsis now live in Pakistan, 
they represent a 'recent' migrant population from Persia (79) and are not included in model 1. Models 
2 and 3 are based on two alternative hypotheses of Parsi origin. Model 2 uses the historical Greater 
Khorasan region as the point of origin of their migration (city of Nishapur, 58.8E 36.2N), as this 
region became a refuge for Zoroastrians following the fall of the Sasanian empire, and subsequent 
migration to India originated from this region (79). The Khorasan region was only a refuge for 
Zoroastrians who used to live in other regions of Persia however, so in Model 3 the Sasanian capital 
Ctesiphon (present-day Iraq, 44.62E 33.15N) is the point of origin of the migration. 
Figure S7
HLA-C characteristics of individuals with HLA-B*73
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Fig. S7. HLA-C characteristics of individuals with HLA-B*73. To investigate how frequently the B*73 
haplotypes also carry the HLA-C*15:05 allele, we summarized data available in the literature and obtained 
genotype data from a large number of bone marrow donors with B*73. Parentheses in the 'Ethnicity' 
column indicate that no ethnicity data were available: the region where the bone marrow registry is located 
was used instead. 'Allele string', lower resolution HLA-typing data. * African-American(s). ** West Asia 
or north African coast. # C*15:05 and C*15:22 could not be distinguished. References: dbMHC (50), ref. 1 
(80), ref.2 (this study), ref. 3 (12), ref. 4 (81) , ref. 5 (82), ref. 6 (78), ref. 7 (83), ref. 8 (84).
Figure S8
HLA-B allelic groups in the African populations that 
diverged before the Out-of-Africa migration
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Fig. S8. HLA-B allelic groups in the African populations that diverged before the Out-of-
Africa migration. HLA-B content is summarized for two Khoisan-speaking (Hadza and 
Khoisan) and three pygmy (Mbenzele, Bakolas and Baka) populations: separations 
between these populations and others represent the earliest splits between modern human 
populations (14, 85). Alleles groups colored green are present in more than one 
population, while those colored blue are present in only one of the five populations. 
References are: ref. 1 (86), ref. 2 (87) and ref. 3 (82). 
Figure S9
HLA-B*73 and HLA-C*15:05 frequencies used for simulations
B
A
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(alleles)
n 
(individuals)
B*73 n 
(alleles)
B*73 
AF
Israel Ashkenazi and Non Ashkenazi Jews 109 5 Both
Israel Arab Druse 100 1 Both
Jordan Amman 146 1 AFN
Oman 121 2 Both
Saudi Arabia pop 2 383 3 AFN
United Arab Emirates 373 15 AFN
Algeria pop 2 106 1 AFN
Burkina Faso Fulani 49 0 AFN
Burkina Faso Mossi 53 1 AFN
Burkina Faso Rimaibe 47 0 AFN
Cameroon Bamileke 77 1 AFN
Cameroon Beti 174 4 AFN
Cameroon Sawa 13 0 AFN
Kenya Luo 265 1 Both
Kenya Nairobi Sex workers 1481 8 This study
Kenya Nairobi 143 0 dbMHC
Kenya Nandi 240 1 Both
Mali Bandiagara 138 0 Both
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Morocco Settat 68 0 dbMHC
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Senegal 94 0 dbMHC
South African Zulu 201 0 dbMHC
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Tunisia 100 0 AFN
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Uganda Kampala pop 2 175 1 AFN
Zambia Lusaka 44 0 Both
Zimbabwe Harare Shona 226 1 Both
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Israel Ashkenazi and Non Ashkenazi Jews 94 5 Both
Israel Arab Druse 100 10 Both
Lebanon 97 1 AFN
Saudi Arabia Guraiat and Hail 213 13 AFN
Cameroon Bamileke 77 1 AFN
Cameroon Beti 174 8 AFN
Cameroon Sawa 13 0 AFN
Kenya 113 1 Both
Kenya Luo 265 3 Both
Kenya Nandi 240 4 Both
Mali Bandiagara 129 0 Both
Morocco Nador Metalsa 73 2 AFN
South African Zulu 96 0 dbMHC
Senegal Niokholo Mandenka 165 0 AFN
Sudanese 200 11 AFN
Tunisia 100 3 AFN
Uganda Kampala 163 1 Both
Uganda Kampala pop 2 175 4 AFN
Zambia Lusaka 45 0 Both
Zimbabwe Harare Shona 226 1 Both
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Summary
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504 29
39
2.88
0.87
Fig. S9. HLA-B*73 and HLA-C*15:05 frequencies used for simulations. (A-B) HLA-
B*73 (A) and C*15:05 (B) frequency data in African and west Asian populations were 
obtained from the Allele Frequency Net (AFN) website (12) or from dbMHC (50). 
Figure S10
Haplotype data used for the B*73 population simulations
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Fig. S10. Haplotype data used for the B*73 population simulations. Haplotype data for 
the population simulations were generated for nine different models of linkage 
disequilibrium (LD) using the B*73 and C*15:05 allele frequencies of figure S9. For 
models 1-3, LD is set at the same percentage for both regions (Africa and west Asia), 
while for models 4-9, a different value is used for each region (west Asia/Africa). 
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Results of HLA-B*73 population simulations
A
B
C  
Name
LD (%)                     
W Asia/Africa
Number Ratio
Ma4 15,008
      
10
Mb4 75 10
Ma4_H 1,660 0.09
Mb4 75 10
a       
(%)
95 / 100 2,354
200
      
95 / 100
Double Accepts
Simulation
Runs 
(/10
6
)
0.041
0.497
Models
Name
LD (%) 
W.Asia/Africa
DF1 DF2 LD1 LD2 Number Ratio
Ma1 14,823
   
10
Mb1 85
          
10
Ma2 7,132
     
5
Mb2 44
          
5
Ma3 6,104
     5
Mb3 44          5
Ma4 15,008   
10
Mb4 75
          
10
Ma5 7,301
     
5
Mb5 35
          
5
Ma6 7,247
     
5
Mb6 42
          
5
Ma7 6,985
     
5
Mb7 58
          
5
Ma8 6,404 5
Mb8 41 5
Ma9 6,409 5
Mb9 37 5
Observed parameters 
(*100)
a 
(%)
0.57
0.61
0.72
0.50
0.48
0.58
0.82
0.64
0.57
95 / 95
90 / 90
95 / 100
100 / 95
95 / 90
Models
174
     
162
     
139     
29.29
29.29
37.34
0.97 0.26
1.06 0.28
1.10 0.28
1.06 0.27
1.10 0.26
31.86
29.34
25.87
29.34
90 / 100
 90 / 95
100 / 100
0.003-0.55
Double Accepts
Derived Fraction (DF) statistic (99% tolerance)                                                                    
Linkage Disequilibrium (LD) statistic (50% tolerance)
34.55
100 / 90
DF1 DF2 LD1
Runs 
(/10
6
)
15.93 47.79-
LD2
Range tolerated (*100)
0.003-0.51
50.48
0.01 2.18- 0.00337.34
34.55
29.29
37.34
31.86
0.53
0.01-1.94
200
     
209
     
0.01-2.10 0.003-
0.01-2.10 0.003-0.55
0.55-
1.06 0.26
1.10 0.27
0.97 0.28
0.97 0.27
0.0134.55 173
156
0.01
0.01
31.86
29.34
25.87
25.87
120
     
173
     
-2.18 0.003-0.53
0.003-
0.53
0.01-2.18 0.003-0.51
0.01-1.94 0.003-
0.51-2.10
-1.94
18.67-53.27 15.93-47.79
17.27-49.22 14.67-
-44.01
44.01
14.64-42.22 12.94-38.81
17.27
18.67-52.01 14.67
-
-38.81
-44.01
14.64-45.22 15.93-47.79
18.67-50.28 12.94-38.81
14.64-43.96 14.67
17.27-47.49 12.94
Name
LD (%) 
W.Asia/Africa
DF1 DF2 LD1 LD2 Number Ratio
Ma4 1,103 > 10
Mb4 - 3,309 30
Observed parameters 
(*100)
a 
(%)
<0.1 0.14-0.42 25.91-43.18 23.90-39.830.53-1.58
Models
Derived Fraction (DF) statistic (50% tolerance)                                                                    
Linkage Disequilibrium (LD) statistic (25% tolerance)
Double Accepts
Runs 
(/10
6
)
Range Tolerated (*100)
DF1 DF2 LD1 LD2
95 / 100 1.06 0.28 34.55 31.86
Fig. S11. Results of HLA-B*73 population simulations. (A-C) Comparison of two 
competing models for the history of B*73: archaic admixture (model a) or African origin 
(model b). Shown are the summary statistics obtained following simulations with both 
models using the parameters indicated at the left. ‘LD’ is linkage disequilibrium between 
the HLA-B and HLA-C alleles. Panel (A) shows simulations 1-9, the input data for which 
are detailed in figure S10, the central columns show the result and the columns at the 
right show the tolerated range. Panel (B) shows simulations with tolerance values halved. 
(C) Simulations using a novel model ‘Ma4_H’, for which an already formed B*73-
C*15:05 haplotype is introduced by admixture. a: confidence level to reject model ‘b’. 
(B-C) Because no significance difference was observed between the nine models of LD 
in the analyses of panel (A), Model 4 was used in these analyses as it best represents the 
observed B*73-C*15 LD in Africa and west Asia (Fig. 1).  
Figure S12
Characterization of the two Denisovan HLA-B alleles
Modern Alleles Differences Modern Alleles Differences Modern Alleles Differences Modern Alleles Differences
B*35:63 4 B*35:63 5 B*35:63 0 B*35:63 1
B*35:03:01 9 B*35:03:01 10 B*35:05:01 6 B*35:05:01 7
B*35:05:01 10 B*35:05:01 11 B*35:01:22 7 B*35:01:22 8
B*35:01:22 11 B*52:01:01:01 11 B*35:03:01 7 B*35:03:01 8
B*35:02:01 11 B*35:01:22 12 B*35:08:01 7 B*35:08:01 8
B*35:08:01 11 B*35:08:01 12 B*35:01:01:02 8 B*35:01:01:02 9
B*52:01:01:01 11 B*35:02:01 12
B*52:01:01:02 12
B*46:01:05 3 B*15:01:01:01 4 B*15:58 3 B*15:58 4
B*15:01:01:01 3 B*15:03:01 4 B*15:17:01:01 4 B*15:17:01:01 5
B*15:03:01 3 B*15:11:01 4 B*15:17:01:02 4 B*15:17:01:02 5
B*15:11:01 3 B*15:18:01 4 B*15:01:01:01 5 B*15:01:01:01 6
B*15:18:01 3 B*15:66 4 B*15:03:01 5 B*15:03:01 6
B*46:01:01 3 B*46:01:01 4 B*15:11:01 5 B*15:11:01 6
B*15:66 3 B*46:01:05 4 B*15:18:01 5 B*15:18:01 6
B*15:07:01 4 B*15:07:01 5 B*15:66 5 B*15:66 6
B*56:03 4 B*56:03 5 B*46:01:01 5 B*46:01:01 6
B*15:108 5 B*15:108 6 B*46:01:05 5 B*46:01:05 6
B*15:27:01 5 B*15:32 6 B*15:07:01 6 B*15:07:01 7
B*15:32 5 B*15:27:01 6 B*56:03 6 B*56:03 7
B*15:58 5 B*15:58 6 B*15:02:01 7 B*15:13 8
B*15:02:01 6 B*15:02:01 7 B*15:108 7 B*15:27:01 8
B*15:13 6 B*15:13 7 B*15:25:01 7 B*15:02:01 8
B*15:17:01:01 6 B*15:17:01:01 7 B*15:32 7 B*15:108 8
B*15:17:01:02 6 B*15:17:01:02 7 B*15:13 7 B*15:25:01 8
B*15:25:01 6 B*15:25:01 7 B*15:27:01 7 B*15:32 8
Mininum 
differences
7 9 3 5
Model 1 Model 2 Model 3 Model 4
Denisova 
Allele 1
Denisova 
Allele 2
Fig. S12. Characterization of the two Denisovan HLA-B alleles. To analyze several 
Denisovan HLA-B sequence reads that could belong to either of the two alleles, we 
investigated all possible combinations and assessed the number of differences with 
modern alleles. The combination that produced the lowest number of differences with 
modern sequences (Model 3) is presented in the main text. 
Figure S13
Putative Denisovan HLA-A-C haplotype frequencies in modern populations 
HLA-A HLA-C Name HF n
Australia Kimberley aborigines A*02:01 C*15:02 B*40:02 8.3 24
Venezuela Sierra de Perija Yucpa A*02:04 C*15:03 B*52:01 5.8 73
Pakistan Sindhi A*02 C*15 B*40 4.3 101
Brazil Guarani-Nandewa A*02:01 C*15:03 B*51:01 2.9 51
Albania A*02 C*15 B*51 2.5 160
Australia Yuendumu Aborigines A*02:01 C*15:02 B*40:02 2.5 190
Venezuela Bari A*02:22 C*15:02 B*51:01 2.2 23
Venezuela Bari A*02:22 C*15:02 B*51:04 2.2 23
Venezuela Bari A*02:22 C*15:07 B*52:01 2.2 23
China Yunnan Hani A*02:03 C*15:02 B*15:01 2.0 150
Israel Druze A*02:01 C*15:05 B*07:02 2.0 100
Taiwan Paiwan A*02:01 C*15:02 B*40:01 2.0 51
Brazil Guarani-Nandewa A*02:01 C*15:03 B*51:04 2.0 51
India New Delhi A*02:01 C*15:07 B*40:06 1.9 53
Brazil Guarani-Nandewa A*02:04 C*15:03 B*51:04 1.8 51
Papua New Guinea Goroka A*02:06 C*15:02 B*40:02 1.6 32
Brazil Guarani-Kaiowa A*02:04 C*15:03 B*51:04 1.5 142
Brazil Guarani-Kaiowa A*02:01 C*15:03 B*51:04 1.2 142
Finnish A*02:01 C*15:02 B*51:01 1.1 90
American Samoa A*02:01 C*15:05 B*40:08 1.0 50
Taiwan Rukai A*02:01 C*15:02 B*56:01 1.0 50
Israel Druze A*02:01 C*15:05 B*44:02 1.0 100
Irish A*02:01 C*15:02 B*51:01 0.6 1000
China Yunnan Hani A*11:01 C*12:02 B*15:07 9.0 150
Taiwan Pazeh A*11:02 C*12:02 B*27:04 8.2 55
India New Delhi A*11:01 C*12:02 B*52:01 5.7 53
Papua New Guinea Haruai A*11:01 C*12:02 B*27:04 5.6 54
Taiwan Atayal A*11:02 C*12:02 B*27:04 3.8 106
Papua New Guinea Madang A*11:01 C*12:02 B*27:04 3.7 54
China Yunnan Han A*11:02 C*12:02 B*27:04 3.5 101
Philippines Ivatan A*11:02 C*12:02 B*15:25 3.0 50
Taiwan Yami A*11:02 C*12:02 B*27:04 3.0 50
Israeli Jews A*11:01 C*12:02 B*52:01 3.0 67
Taiwan Siraya A*11:02 C*12:02 B*27:04 2.9 51
Taiwan Siraya A*11:02 C*12:02 B*40:02 2.9 51
Taiwan Puyuma A*11:02 C*12:02 B*27:04 2.7 50
China Yunnan Bulang A*11:01 C*12:02 B*15:07 2.5 116
Papua New Guinea Wosera A*11:01 C*12:02 B*27:04 1.6 95
Russia Tuva A*11:01 C*12:02 B*52:01 1.5 166
Papua New Guinea Wosera A*11:01 C*12:02 B*39:01 1.1 95
Taiwan Ami A*11:02 C*12:02 B*27:04 1.0 98
Philippines Ivatan A*11:02 C*12:02 B*27:04 1.0 50
A*02 C*12:02 Taiwan Puyuma A*02:06 C*12:02 B*27:04 2.8 50
Papua New Guinea Wosera A*11:01 C*15:02 B*40:02 20.5 95
Australia Groote Eylandt aborigines A*11:01 C*15:02 B*40:02 7.5 73
Papua New Guinea Haruai A*11:01 C*15:02 B*40:02 7.4 54
Australia Yuendumu aborigines A*11:01 C*15:02 B*40:02 6.2 190
Pakistan Brahui A*11 C*15 B*40 6.0 104
Pakistan Baloch A*11 C*15 B*40 5.4 66
India New Delhi A*11:01 C*15:07 B*40:06 4.7 53
Iran Baloch A*11:01 C*15:02 B*40:06 3.4 100
Israel Druze A*11:01 C*15:02 B*51:01 3.0 100
Pakistan Sindhi A*11 C*15 B*40 2.6 101
New Caledonia A*11:01 C*15:02 B*40:02 2.6 39
Australia Kimberley aborigines A*11:01 C*15:02 B*40:02 2.1 24
Papua New Guinea Goroka A*11:01 C*15:02 B*40:02 1.6 32
Taiwan Pazeh A*11:01 C*15:02 B*40:01 1.1 55
Papua New Guinea Haruai A*11:01 C*15:02 B*15:06 0.9 54
Haplotype
Modern populations with haplotypes resembling the Denisovan                                            
HLA class I  haplotypes  
C*12:02
C*15
Putative 
Denisovan 
HLA-A-C 
haplotypes
1
2
A*11
A*11
A*02
C*15
Denisovan                 
HLA class I  loci
Fig. S13. Putative Denisovan HLA-A-C haplotype frequencies in modern populations. 
Shown are the frequencies in modern humans of haplotypes carried by the Denisovan 
individual. Although phase could not be unambiguously determined, there are only two 
possible combinations (1 and 2, left column), and thus four possible haplotypes of the 
Denisovan HLA-A and -C. All four haplotypes exist in modern human populations. They 
are shown together with the specific HLA-B allele associated with that haplotype in each 
population. HF gives the allele frequency of the haplotype. Some populations shown here 
were too small (n<40) to be included in the distribution maps.  
Figure S14
Distribution of the Denisovan HLA class I alleles
B
A
Number Country
B*15:58-like 4 China (3), Korea (1)
B*35:63 1 Korea
Observations (IMGT/HLA) Denisovan  
allele
Allele Population Freq. (%)
Papua New Guinea Madang 63.6
China Yunnan Province Hani 61.3
China Yunnan Province Wa 58.4
Papua New Guinea West Schrader 
Ranges Haruai
55.0
China Yunnan Province Bulang 54.3
China Yunnan Province Nu 51.9
China Yunnan Province Lisu 51.2
China Guangdong Province Meizhou 
Han
48.6
China Southwest Dai 41.9
China Guizhou Province Miao 41.8
Australia Kimberly Aborigine 28.6
Papua New Guinea Wosera Abelam 23.2
Australia Yuendumu Aborigine 20.3
Pakistan Baloch 18.9
Pakistan Brahui 18.3
Iran Baloch 17.7
India Kerala Hindu Namboothiri 16.3
India Khandesh Region Pawra 16.0
India Kerala Hindu Nair 14.6
India New Delhi 14.3
India Khandesh Region Pawra 15.0
India West Bhil 14.0
Japan (4 pops) 10.4-12.1
Papua New Guinea Wosera Abelam 11.6
Taiwan Pazeh 10.9
China Yunnan Province Hani 10.3
Pakistan Sindhi 10.2
Pakistan Burusho 10.2
Italy Sardinia 10.0
Iran Tehran 9.8
A*11
C*15
C*12:02
Fig. S14. Distribution of the Denisovan HLA class I alleles. (A) Denisovan A*11, C*15 
and C*12:02 are common in modern humans. Ten populations with the highest allele 
frequencies are shown. (B) While Denisovan HLA-B alleles are absent or rare in modern 
humans, their closest modern genomic relatives are characteristically Asian. Number in 
parentheses indicate the number of observations reported in the IMGT-HLA Database 
(10). B*35:63 is a recombinant with B*40:01-like exon 2 and B*35:01 background.  
Figure S15
Emergence of A*11, C*15 and C*12:02
A  A*01:01
 A*01:03
 A*11:01
 A*11:53
 A*03:01
 A*03:02
 A*30:01
 A*30:04
 Patr-A*03:02
 Patr-AL(1)
 Patr-AL(2)
 Popy-A*05:01
 Popy-A*04:01
 Popy-A*02
 Popy-A*03:02
 Mamu-A2
 Mamu-A3
 Mamu-AG3
 Mamu-AG4
0.01
[6.5-10 MYA]
[>10 MYA]
[23-33.9 MYA]
1.83 [0.75-3.57] MYA
B  Popy-C*02:02
 Patr-C*17:01
 C*02:02:02
 C*02:11
 C*02:16:02
 C*15:16
 C*15:17
 C*15:02:01
 C*15:13
 C*15:05:02
0.001
[10-18 MYA]
[6.5-10 MYA]
4.35 [2.26-7.21] MYA
1.48 [0.44-3.87] MYA
73
*
53
 Popy-C*02:02
 Patr-C*17:01
 C*12:22
 C*12:02:02
 C*12:08
 C*12:03:01
 C*12:19
 C*06:24
 C*06:02:01
0.001
C
[10-18 MYA]
[6.5-10 MYA]
52
*
54
3.74 [1.03-7.31] MYA
2.63 [0.66-5.81] MYA
1.21 [0.23-3.17] MYA
Fig. S15. Emergence of A*11, C*15 and C*12:02. (A-C) Divergence time estimates for 
the emergence of A*11 (A), C*15 (B) and C*12:02 (C). Phylogenetic analyses and 
display are as described in the legend to figure S3. At nodes, red characters indicate the 
fossil calibrations used for these analyses, while blue characters give the estimated age of 
the nodes (mean and 95% credibility interval). MYA, million years ago.  
Figure S16
Haplotype diversity of A*11, C*15 and C*12:02
A
B
Pops
HLA-A HLA-C n
A*11[:01] C*01[:02] 12 7.5
A*11[:01/02] C*03[:02/03/04] 14 12.0
A*11[:01/02] C*04[:01/03] 25 33.8
A*11[:01/02] C*07[:01/02/04] 19 20.2
A*11[:01/02/04] C*08[:01] 17 22.9
A*11[:01/02] C*12[:02/03] 16 14.0
A*11[:01] C*14[:02] 5 3.9
A*11[:01] C*15[:02/07] 7 6.0
A*11[:01] C*01[:02] 7 13.9
A*11[:01] C*03[:03/04] 6 9.3
A*11[:01] C*04[:01/03] 8 32.5
A*11[:01] C*07[:01/02] 5 14.8
A*11[:01] C*08[:01] 2 2.5
A*11[:01] C*12[:02/03] 4 5.6
A*11[:01] C*15[:02] 4 20.5
A*11[:01] C*03[:03/04] 2 2.2
A*11[:01] C*04[:01] 3 4.0
A*11[:01] C*05[:01] 1 0.4
A*11[:01] C*07[:01/02] 1 2.1
N.Africa A*11[:01] C*01 1 2.0
Max 
HF
Haplotypes
Region
A*11
Asia
Europe
Pacific 
Islanders / 
Australia
Pops Max
HLA-C HLA-B n HF
C*15[:05] B*07[:02/05] 3 4.7
C*15[:02/03] B*15[:01/04] 3 6.0
C*15[:02] B*27[:07] 1 2.5
C*15[:04/05] B*35[:01] 2 1.5
C*15[:02/07] B*40[:01/02/06] 13 11.1
C*15[:05] B*44[:02] 1 1.0
C*15[:02/03/05] B*51[:01/04] 12 9.5
C*15[:03] B*52[:01] 1 12.8
C*15[:02] B*56[:01] 3 5.0
C*15[:02] B*15[:06/25] 2 3.2
C*15[:02/05/07] B*40[:02/08/12] 6 20.5
Europe C*15[:02] B*51:[01] 3 2.5
N. Africa C*15[:02] B*51[:01] 1 2.5
C*15[:05] B*07[:02] 1 1.1
C*15[:02] B*51[:01] 1 0.4
C*12[:02] B*15[:07/25] 3 9.0
C*12[:02] B*27[:04] 9 10.9
C*12[:02] B*40[:02/06] 2 4.9
C*12[:02] B*44[:04] 1 1.4
C*12[:02] B*52[:01] 7 10.7
C*12[:02] B*53[:03] 1 5.8
C*12[:02] B*56[:01] 1 1.0
C*12[:02] B*27[:04] 3 5.6
C*12[:02] B*39[:01] 1 1.1
N. Africa C*12[:02] B*52[:01] 1 2.0
African American C*12[:02] B*52[:01] 1 0.1
C*15
C*12:02
Region
Haplotypes
Asia/Americas
Asia
Pacific Islanders/ Australia
Pacific Islanders/ Australia
African American
Fig. S16. Haplotype diversity of A*11, C*15 and C*12:02. Shown are all of the 
haplotypes in modern populations that contain one of the three HLA alleles, A*11, C*15 
or C*12:02, identified in the Denisovan individual (A) HLA-A/C. (B) HLA-B/C: C*15 
and C*12:02 are found at low frequencies in Africa but because their haplotype 
frequencies are <1%, their haplotype structures in Africa are not reported in databases. 
To investigate HLA-B/C haplotype structures for these two alleles in Africa, we used data 
from a study of ~2,400 African-American donors, in which all the haplotypes were 
defined and reported (62). Allele subtypes listed in brackets were all observed.  
Figure S17
HLA-A, B, and C alleles of three Neandertals
Allele # Reads
1 25 A*02
2 5 A*26/*66
1 14 B*07/*48
2 21 B*51/*52/*78
1 30 C*07:02
2 19 C*16:02
1 7 A*02
2 8 A*26/*66
1 5 B*07/*48
2 10 B*51/*53
1 10 C*07:02
2 5 C*16
1 6 A*02
2 3 A*26/*31/*34/*66
1 10 B*07/*48
2 12 B*51/*52/*78
1 12 C*07:02
2 7 C*16
Allele(s)
Most closely related 
modern allele group
SLVi33.25
Name Reads
SLVi33.16
HLA-B 28
HLA-C 75
HLA-A
57
35
49
HLA-B
SLVi33.26
Individuals
Neandertal HLA class I loci
Specific gene 
coverage
HLA-B 45
HLA-C 35
HLA-C 22
HLA-A 28
HLA-A
Fig. S17. HLA-A, B, and C alleles of three Neandertals. HLA-A, B, and C types were 
investigated for each of the three Neandertal individuals whose genome was sequenced 
(3). For each individual a precise type was obtained for two HLA-C alleles and one HLA-
A allele. For the other alleles, the type is given as a string, listing all possible types.  
Figure S18
Modern populations with two high-frequency HLA-C alleles
Name n Name Frequency Two related All unrelated
C*04 0.412
C*14 0.412
C*02 0.520
C*07 0.289
C*12 0.300
C*14 0.500
C*03 0.409
C*07 0.303
C*04 0.373
C*07 0.333
C*04 0.300
C*14 0.400
C*01 0.302
C*04 0.396
C*03 0.290
C*04 0.410
C*04 0.306
C*07 0.381
C*03 0.402
C*07 0.275
C*01 0.375
C*15 0.286
C*04 0.340
C*07 0.310
C*04 0.345
C*07 0.302
C*03 0.327
C*07 0.318
C*04 0.378
C*07 0.273
C*01 0.267
C*04 0.377
C*02 0.250
C*07 0.400
C*03 0.320
C*08 0.300
C*04 0.280
C*07 0.320
C*03 0.350
C*14 0.250
C*06 0.280
C*07 0.306
C*03 0.251
C*07 0.330
C*03 0.283
C*07 0.288
C*04 0.293
C*07 0.278
0.0043
0.0071
0.0058
0.0054
0.0050
0.0045
0.0043
0.0094
0.0090
0.0090
0.0088
0.0082
0.0080
0.0138
0.0137
0.0134
0.0127
0.0108
0.0099
0.0092
0.0086
0.0080
0.0076
0.0076
0.0391
0.0272
0.0270
0.0152
0.0153
0.0139
0.0139
0.0131
0.0130
0.0114
0.0096
0.0198
0.0187
0.0165
0.0152
0.0144
0.0140
106
46
Population
0.0475
0.0365
0.0360
0.0219
0.0218
0.0202
0.0200
10
50
25
10
27
200
41
34
65
55
55
75
103
15
57
50
90
51
HLA-C alleles
p of having three 
individuals with the 
same two alleles
17
36
10
55
Malaysia Kelantan
India Kerala Malapandaram
Sudan East Rashaida
Norway Sami
Taiwan Atayal
Sudan South Nuba
Papua New Guinea Madang
Taiwan Taroko
Mexico Oaxaca Mixe
Australia Groote Eylandt Aborigine
Cameroon Baka Pygmy
Taiwan Puyuma
Papua New Guinea Eastern Highlands Goroka Asaro
Taiwan Tao
Mexico Oaxaca Zapotec
Taiwan Tsou
Australia Kimberly Aborigine
Malaysia Negeri Sembilan Minangkabau
India Kerala Kattunaikka
Central African Republic Mbenzele Pygmy
India Kerala Paniya
Venezuela Perja Mountain Bari
Mexico Oaxaca Mixtec
India Kerala Kuruma
Fig. S18. Modern populations with two high-frequency HLA-C alleles. For modern human 
populations, the probability of three randomly selected, unrelated individuals having the same two 
HLA-C alleles is small. Displayed are the 24 populations (out of ~250) with the highest probabilities 
of producing three individuals with the same two HLA-C allotypes as they have two high frequency 
HLA-C alleles. Of these the top 10 have probabilities of 1-5%. Even if two of the three individuals 
are maternally-related (3), this number would only increase from 10 to 18. The probability 
calculation was made as follows: one individual randomly selected from a population having two 
alleles of frequencies x and y will have a probability p=2*(x*y) to have one copy of each allele. The 
3
probability of three unrelated individuals having the same allelic content is (2*(x*y)) .
Figure S19
Putative Neandertal HLA-A-C haplotype
frequencies in modern populations
HLA-A HLA-C
Venezuela Yucpa 26.9 73
USA Canoncito Navajo 13.1 41
China Yunnan Lisu 10.4 111
Ireland Northern 5.1 1,000
Philippines Ivatan 4.7 50
China Yunnan Bulang 4.3 116
China Yunnan Nu 4.1 107
Finn 3.9 90
China Guizhou Bouyei 3.3 109
China Yunnan Hani pop 2 3.0 150
Russia Bering Island Aleut 2.8 85
Taiwan Pazeh 2.7 55
China Southwest Dai 2.6 124
Taiwan Saisiat 2.6 51
Taiwan Paiwan 2.0 51
Brazil Guarani-Nandewa 2.0 51
Georgian 1.9 104
India New Delhi 1.9 53
Taiwan Siraya 1.8 51
Taiwan Ami 1.5 98
Vietnam Hanoi Kinh pop 2 1.5 170
Czech 1.4 104
Russia Tuva 1.4 166
Poland 1.3 200
Australia Yuendumu 1.2 190
Zambian 1.2 43
Iran Baloch 1.1 100
American Samoa 1.0 50
Taiwan Puyuma 1.0 50
Taiwan Rukai 1.0 50
Pakistan Pathan 3.4 100
Georgian 1.4 104
Taiwan Taroko 10.8 55
Pakistan Burusho 6.0 92
Taiwan Rukai 5.4 50
Taiwan Bunun 5.3 101
Pakistan Sindhi 5.0 101
Taiwan Atayal 4.3 106
Pakistan Pathan 3.8 100
India New Delhi 3.8 53
Taiwan Siraya 2.0 51
Taiwan Saisiat 1.2 51
Iran Baloch 1.1 100
Filipino 1.1 94
American Samoa 1.0 50
Europe, Asia
#
Rare
A*26 C*07:02
C*16:02A*02
A*26 C*16:02
Population n
HLA-A-C haplotype
HF
A*02 C*07:02
Fig. S19. Putative Neandertal HLA-A-C haplotype frequencies in modern populations. 
The two HLA-A and two HLA-C alleles of the three Neandertals can form four possible 
haplotypes: their frequencies (HF) in modern human populations are shown. #, haplotype 
was observed in large cohorts of registry donors (62) but not in anthropology studies with 
HF>1%.  
Figure S20
Allele frequency distributions for HLA-A*02 and A*26/*66 
B
A
HLA-A*26
4.0
0.0
12.0
21.8
8.0
HLA-A*66
2.0
0.0
13.6
6.0
4.0
8.0
C
10.0
0.0
30.0
41.0
20.0
40.0
HLA-A*02
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(%)
af
(%)
af
(%)
Fig. S20. Allele frequency distributions for HLA-A*02 and A*26/*66. (A-C) In addition 
to A*02, a common allele group worldwide (A), the HLA-A genotype of one Neandertal 
allele could not be determined precisely enough for careful distribution analyses: the 
genotype of this HLA-A allele was narrowed down to two possibilities (A*26/*66) but 
while A*26 is most common in Eurasia (B), A*66 is more common in Africa (C). 
Figure S21
Distribution of Neandertal HLA class I alleles
Allele Population Freq. (%) Allele Population Freq. (%)
A*26 Taiwan Aborigines (3 pops) 14-21.8 A*66 Cameroon Bakola Pygmy 14.5
Japan (8 pops) 10.8-19 Kenya Luo 7.7
Israel Ashkenazi Jews 15.4 Uganda Kampala pop 2 7.5
Turkey 13.5 Cameroon Yaounde 7.1
Pakistan Baloch 10.3 Cameroon Beti 5.5
Oman 10.2 Kenya Nandi 5.4
Pakistan Burusho 9.8 Cameroon Bamileke 5.1
China Yunnan Province Jinuo 9.6 Tunisia Ghannouch 4.3
Mongolia Hoton 9.4 Zimbabwe Harare Shona 4.2
Mongolia Tarialan Khoton 9.4 India West Bhil 4.0
B*07:02/03/06 Sweden Northern Sami 19.0 B*51:01/08 Bulgaria 20.9
Sweden Southern Sami 18.6 Japan Hokkaido Ainu 19.0
Ireland Northern 17.3 Oman 17.8
England North West 15.3 China Tibet Region Tibetan 16.8
Finland 14.4 Georgia Tibilisi 16.7
Austria 12.9 China North Han 15.8
Poland 12.1 Georgia Svaneti Region Svan 15.6
Russia Bering Island Aleut 10.0 India Tamil Nadu Nadar 15.6
Croatia 9.7 Saudi Arabia Guraiat and Hail 15.6
Azores Santa Maria and Sao Miguel 9.0 India Andhra Pradesh Golla 14.4
C*07:02 Venezuela Sierra de Perija Yucpa 71.4 C*16:02 Pakistan Pathan 5.5
Taiwan Saisiat 66.7 Iran Tehran 4.9
Papua New Guinea East New Britain Rabaul 57.1 Georgia Tibilisi 4.2
Mexico Oaxaca Mixtec 33.3 Spain Andalusia 3.7
China Yunnan Province Lisu 32.9 Tunisia 3.0
Taiwan Taroko 31.8 Pakistan Kalash 2.9
China Yunnan Province Nu 30.7 Iran Baloch 2.6
Venezuela Perja Mountain Bari 30.3 India Delhi 2.5
Papua New Guinea Madang 30.2 Italy North 2.3
Taiwan Atayal 28.8 Jordan Amman 2.1
Fig. S21. Distribution of Neandertal HLA class I alleles. Neandertal alleles are common 
in modern humans. For each assigned allele or candidate allele the 10 populations with 
the highest allele frequencies are given. 
Figure S22
Haplotype diversity of B*07:02/03/06, B*51:01/08, C*07:02 and C*16:02
Pops
HLA-C HLA-B n
C*03[:04] B*51[:01] 2 9.0
C*04[:03] B*51[:01] 1 2.0
C*07[:01] B*51[:01] 1 2.8
C*14[:02] B*51[:01] 12 9.1
C*15[:02/03/05] B*51[:01] 10 4.9
C*16[:02] B*51[:01/08] 2 1.4
C*01[:02] B*51[:01] 1 2.8
C*14[:02] B*51[:01] 1 1.8
C*15[:02] B*51[:01] 2 1.1
C*15[:02] B*51[:01] 1 2.5
C*16[:02] B*51[:01] 1 2.0
Sub-Saharan Africa C*16[:01/02] B*51[:01] 4 4.0
C*04[:01] B*07[:02] 1 1.6
C*07[:02/04] B*07[:02] 16 6.5
C*15[:05] B*07[:02] 1 2.0
Europe C*07[:02] B*07[:02] 4 17.0
Sub-Saharan Africa C*07[:01/02] B*07[:02] 8 4.3
C*07[:02] B*07[:02/05] 19 6.5
C*07[:02] B*08[:01] 6 14.8
C*07[:02] B*13[:01] 3 1.6
C*07[:02] B*15[:03/25/32/35/36] 7 5.9
C*07[:02] B*18[:01] 1 0.9
C*07[:02] B*27[:04] 1 0.9
C*07[:02] B*35[:01] 2 6.0
C*07[:02] B*38[:01/02] 14 14.9
C*07[:02] B*39[:01/02/03/05/06/08/09/11] 26 71.1
C*07[:02] B*40[:01/02/06] 20 11.8
C*07[:02] B*46[:01] 3 1.8
C*07[:02] B*48[:01/03] 2 1.5
C*07[:02] B*52[:01] 4 17.6
C*07[:02] B*55[:02] 2 3.0
C*07[:02] B*56[:01/02] 7 22.2
C*07[:02] B*58[:01] 2 2.7
C*07[:02] B*67[:01] 1 1.1
C*07[:02] B*07[:02] 4 17.0
C*07[:02] B*39[:01] 1 1.1
N.Africa C*07[:02] B*08[:01] 1 2.0
C*07[:02] B*07[:02] 8 4.3
C*07[:02] B*08[:01] 2 1.6
C*16[:02] B*40[:06] 1 1.1
C*16[:02] B*51:[01/08] 5 5.9
N.Africa C*16[:02] B*51[:01] 1 2.0
Sub-Saharan Africa C*16[:02] B*51[:01] 1 1.3
Asia
C*16:02
Sub-Saharan Africa
C*07:02
B*07:02/03/06
Asia / Americas 
/Oceania
B*51:01/08
N.Africa
Europe
Asia / Americas
Max 
HF
Haplotypes
Region
Europe
Asia / Americas 
/Oceania
Fig. S22. Haplotype diversity of B*07:02/03/06, B*51:01/08, C*07:02, and C*16:02. 
Diversity of the HLA-B-C haplotypes carrying B*07:02/03/06, B*51:01/08, C*07:02, and 
C*16:02 in modern populations. Allele subtypes listed in brackets were all observed.  
Figure S23
Enhanced HLA class I LD decay significantly correlates with archaic ancestry
B
A
African European Chinese Japanese
27 29 28 22
Number 3 4 3 6
--- 15:01
18:01 --- ---
35:01
--- 37:01 ---
--- 39:05 --- ---
--- 40:02
--- --- 40:06
51:01 51:01 51:01
53:01 --- --- ---
--- --- 54:01
56:01
--- --- 59:01
--- --- 67:01
81:01 --- ---
African European Chinese Japanese
16 17 13 15
Number 5 6 3 6
01:02 01:02 01:02
02:02 02:02 --- ---
03:02 ---
--- 03:03 03:03
--- 03:04
04:01
07:01 --- ---
07:02 07:02
--- 07:04
--- 08:01 08:01
14:02 14:02
--- 15:02
16:01 --- ---
Defining 
allele 
name 
(C* )
Population
Allele-specific 
haplotypes 
with             
enhanced               
LD decay
Population
Allele-specific 
haplotypes 
with             
enhanced               
LD decay
Distinct alleles
HLA-B
Defining 
allele 
name 
(B* )
HLA-C
Distinct alleles
Fig. S23. Enhanced HLA class I LD decay significantly correlates with archaic ancestry. 
(A-B) Shown for each HapMap population are (top row) the number of distinct HLA-B or 
HLA-C alleles present and (second row) the number exhibiting enhanced LD decay (all 
allele-defining SNPs (r
2
>0.2) are within 500kb of HLA-A (31)). The allele names are 
listed (rows 3-14) and colored green when observed in archaic humans (Figs 2-3) or 
associated with archaic-origin haplotypes (fig. S25). HLA-A is shown in Fig. 4. ---, absent 
in the population.  
Figure S24
HLA-C alleles linked to B*73 when C*15 is absent
Frequency: all haplotypes 
+ SE (%) 
Frequency: B*73  haplotypes 
+ SE (%) 
(n=92) (n=47)
C*12:02 - B*73:01 14.9+3.7        29.2+7.3
C*02:02 - B*73:01 9.8+3.1 19.1+6.1
C*06:02 - B*73:01 5.4+2.4 10.6+4.6
C*16:01 - B*73:01 3.3+1.9 6.4+3.6
C*04:01 - B*73:01 3.1+1.8 6.1+3.6
C*07:01 - B*73:01 2.8+1.7 5.4+3.3
HLA-C-B         
haplotype
Fig. S24. HLA-C alleles linked to B*73 when C*15 is absent. HLA-C-B haplotype 
structures were determined for 46 B*73
+
 individuals lacking C*15 (fig. S7), and B*73 
haplotypes observed at least twice are listed with their estimated frequency (n=92, all 
haplotypes; n=47, B*73 haplotypes only). SE, standard error. 
Figure S25
Alleles associated with Denisovan/Neandertal-like haplotypes
Main haplotype
2-locus haplotype Denisovan HLA-A-C Neandertal HLA-A-B Neandertal HLA-A-C
Third locus HLA-B HLA-C HLA-B
*07:02 *01:02 *07:02/05
*15:01/06/07/25 *02:02 *08:01
*27:04 *04:01 *15:01/03/25
*39:01 *07:01/02 *18:01
*40:01/02/06/08 *14:02 *35:01
*44:02 *15:02/03/05 *38:01/02
*51:01/04 *16:01/02 *39:01/03/05/06
*52:01 *40:01/06
*56:01 *48:01
*51:01
*52:01
*56:01
*67:01
Alleles of the 
third locus 
present on 
modern human 
haplotypes
Archaic human-like haplotypes
Fig. S25. Alleles associated with Denisovan/Neandertal-like haplotypes. Shown is each 
category of two-locus archaic haplotypes we inferred, together with the allele at the third 
locus that is present on the equivalent modern-human haplotype. Every HLA-B allele that 
is found in modern humans on at least one of the four Denisovan-like HLA-A-C 
haplotypes is shown in column 3. The third and fourth columns give the HLA-C and 
HLA-B alleles found on the Neandertal-like HLA-A-B and HLA-A-C haplotypes, 
respectively. 
Figure S26
Population recombination rates for the HLA class I region
Mean SD
African 1.00 0.06
European 0.70 0.06
Japanese 1.21 0.13
Chinese 1.33 0.13
African 0.96 0.08
European 0.70 0.07
Japanese 1.14 0.11
Chinese 1.18 0.12
African 1.54 0.31
European 2.13 0.48
Japanese 3.12 0.64
Chinese 4.88 1.00
r
4
 (*10 )
HLA-A-B 
(~1.4Mb)
HLA-A-C 
(~1.3Mb)
Genomic 
region
HLA-C-B 
(~85kb)
Population
Fig. S26. Population recombination rates for the HLA class I region. Population 
recombination rates (r) for four populations and three HLA class I intervals.  
